<SEC-DOCUMENT>0001453687-24-000084.txt : 20240522
<SEC-HEADER>0001453687-24-000084.hdr.sgml : 20240522
<ACCEPTANCE-DATETIME>20240522070848
ACCESSION NUMBER:		0001453687-24-000084
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240522
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240522
DATE AS OF CHANGE:		20240522

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cartesian Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001453687
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37798
		FILM NUMBER:		24971632

	BUSINESS ADDRESS:	
		STREET 1:		65 GROVE STREET
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		617-923-1400

	MAIL ADDRESS:	
		STREET 1:		65 GROVE STREET
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SELECTA BIOSCIENCES INC
		DATE OF NAME CHANGE:	20090109
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>rnac-20240522.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:91e8fb68-b1c6-4cbe-975b-d4c9e7616946,g:a1fed2b6-6cbb-4849-98a6-a76e3179c4d7,d:b3ced7300a4e443b8811d238a4a02d24-->
<html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rnac-20240522</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0001453687</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-22">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rnac-20240522.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001453687</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-22</xbrli:startDate><xbrli:endDate>2024-05-22</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ib3ced7300a4e443b8811d238a4a02d24_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d)&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">the Securities Exchange Act of 1934</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">May 22, 2024</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">CARTESIAN THERAPEUTICS,&#160;INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:29.793%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.793%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.560%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.794%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-37798</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">26-1622110</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction <br/>of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">   </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">704 Quince Orchard Road,</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Gaithersburg,</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">MD</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">20878</ix:nonNumeric> </span></div><div style="text-align:center;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices)(Zip Code)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">617</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">923-1400</ix:nonNumeric> </span></div><div style="text-align:center;text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:10.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.334%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:39.515%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.517%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock (Par Value $0.0001)</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">RNAC</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:7pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib3ced7300a4e443b8811d238a4a02d24_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.01  Regulation FD Disclosure.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 22, 2024, Cartesian Therapeutics, Inc. (&#8220;the Company&#8221;) issued a press release announcing that the U.S. Food and Drug Administration (&#8220;FDA&#8221;) has granted Regenerative Medicine Advanced Therapeutic (&#8220;RMAT&#8221;) designation for Descartes-08 for the treatment of myasthenia gravis (&#8220;MG&#8221;). A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in Item 7.01 of this Form 8-K (including Exhibit 99.1 attached hereto) shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01  Other Events.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 22, 2024, the Company announced that the FDA granted RMAT designation for Descartes-08 for the treatment of MG. </span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Descartes-08, the Company&#8217;s lead product candidate, is an autologous mRNA CAR-T directed against the-B cell maturation antigen initially being developed for the treatment of MG,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> a chronic autoimmune disorder that causes disabling muscle weakness and fatigue. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01  Financial Statements and Exhibits.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;Exhibits</span></div><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:83.088%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="rnac_05222024xrmatdesignat.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="rnac_05222024xrmatdesignat.htm">Press Release Issued by Cartesian Therapeutics, Inc. on May 22, 2024</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib3ced7300a4e443b8811d238a4a02d24_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:47.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.178%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CARTESIAN THERAPEUTICS,&#160;INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May 22, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Carsten Brunn, Ph.D.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carsten Brunn, Ph.D.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>rnac_05222024xrmatdesignat.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i7b446bbf48ae49a7881b31c3af6b53be_1"></div><div style="min-height:77.76pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div style="text-align:right"><img alt="image_0.jpg" src="image_0.jpg" style="height:55px;margin-bottom:5pt;vertical-align:text-bottom;width:181px"></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Topline data from Phase 2b trial of Descartes-08 in myasthenia gravis remains on track for mid-2024</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">GAITHERSBURG, MD, May 22, 2024 (GLOBE NEWSWIRE) &#8211; </font><font style="color:#242424;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cartesian Therapeutics, Inc. (NASDAQ&#58; RNAC) (the &#8220;Company&#8221;), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that the U.S. Food and Drug Administration (&#8220;FDA&#8221;) has granted Regenerative Medicine Advanced Therapy (&#8220;RMAT&#8221;) designation for Descartes-08 for the treatment of myasthenia gravis (&#8220;MG&#8221;). </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#242424;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Descartes-08, the Company&#8217;s lead product candidate, is an autologous mRNA CAR-T directed against the B cell maturation antigen (&#8220;BCMA&#8221;) initially being developed for the treatment of MG,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> a chronic autoimmune disorder that causes disabling muscle weakness and fatigue. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#242424;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8220;Receipt of RMAT designation underscores our belief that Descartes-08, our potential first-in-class mRNA CAR-T cell therapy, could serve as a meaningful addition to the MG treatment landscape,&#8221; said Carsten Brunn, Ph.D., President and Chief Executive Officer of Cartesian. &#8220;We look forward to working closely with the FDA to efficiently advance the development of Descartes-08 for this underserved population. Looking ahead, we remain on track to report topline data from our ongoing Phase 2b study in patients with MG in the middle of this year.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#242424;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Established under the 21st Century Cures Act, a product candidate is eligible for RMAT designation if it is a regenerative medicine therapy intended to treat, modify, reverse, or cure a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug or therapy has the potential to address unmet medical needs for such disease or condition. Receiving RMAT designation offers sponsor companies the benefits of the fast track and breakthrough therapy designation programs, allowing for early, close, and frequent interactions with the FDA with the goal of expediting drug development.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Descartes-08 was previously granted Orphan Drug Designation by the FDA for the treatment of MG.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In January 2024, Cartesian&#160;</font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/0001453687/000114036124001205/ny20014884x2_ex99-2.htm" style="color:#0563c1;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline">announced</a></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;positive twelve-month follow-up data from its Phase 2a study of Descartes-08 in patients with generalized MG. In this study, Descartes-08 was administered in an outpatient setting without integrating vectors or preconditioning chemotherapy, and durable depletion of autoantibodies and clinically meaningful improvements in MG severity scores during the one-year follow-up period were observed. Descartes-08 was observed to be well-tolerated, with no dose-limiting toxicities, cytokine release syndrome, or neurotoxicity.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company remains on track to report topline data from its Phase 2b randomized, double-blind, placebo-controlled trial of Descartes-08 in patients with MG (NCT04146051) in mid-2024.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">About Cartesian Therapeutics</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cartesian Therapeutics is a clinical-stage company pioneering mRNA cell therapies for the treatment of autoimmune diseases. The Company&#8217;s lead asset, Descartes-08, is a potential first-in-class mRNA CAR-T in Phase 2b clinical development for patients with generalized myasthenia gravis. Additional Phase 2 studies are planned in systemic lupus erythematosus under an allowed IND, as well as basket trials in additional autoimmune indications. The Company&#8217;s clinical-stage pipeline also includes Descartes-15, a next-generation, autologous anti-BCMA mRNA CAR-T.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Forward Looking Statements</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Any statements in this press release about the future expectations, plans and prospects of the Company, including without limitation, statements regarding the Company&#8217;s headquarters relocation, the Company&#8217;s manufacturing capabilities and ability to support necessary quantities of its product candidates for clinical trials and potential commercialization, the Company&#8217;s ability to maintain control over its product quality and production, the potential of the Company&#8217;s technology to enable precision control and optimization of engineered cells for diverse cell therapies leveraging multiple modalities, the potential of Descartes-08 and Descartes-15 and the Company&#8217;s other product candidates to treat myasthenia gravis, systemic lupus erythematosus, or any other disease, the anticipated initiation timing of planned clinical trials, the anticipated timing or the outcome of ongoing and planned clinical trials, studies </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:77.76pt;width:100%"><div style="text-align:right"><img alt="image_0.jpg" src="image_0.jpg" style="height:55px;margin-bottom:5pt;vertical-align:text-bottom;width:181px"></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and data readouts, the anticipated timing or the outcome of the FDA&#8217;s review of the Company&#8217;s regulatory filings, the Company&#8217;s ability to conduct its clinical trials and preclinical studies, the timing or making of any regulatory filings, the anticipated timing or outcome of selection of developmental product candidates, the ability of the Company to consummate any expected agreements and licenses and to realize the anticipated benefits thereof, the novelty of treatment paradigms that the Company is able to develop, the potential of any therapies developed by the Company to fulfill unmet medical needs, the Company&#8217;s ability to enter into and maintain its strategic partnerships, and enrollment in the Company&#8217;s clinical trials, and other statements containing the words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;hypothesize,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;would,&#8221; and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including, but not limited to, the following&#58; the uncertainties inherent in the initiation, completion and cost of clinical trials including proof of concept trials, including uncertain outcomes, the availability and timing of data from ongoing and future clinical trials and the results of such trials, whether preliminary results from a particular clinical trial will be predictive of the final results of that trial and whether results of early clinical trials will be indicative of the results of later clinical trials, the ability to predict results of studies performed on human beings based on results of studies performed on non-human subjects, the unproven approach of the Company&#8217;s technology, potential delays in enrollment of patients, undesirable side effects of the Company&#8217;s product candidates, its reliance on third parties to conduct its clinical trials, the Company&#8217;s inability to maintain its existing or future collaborations, licenses or contractual relationships, its inability to protect its proprietary technology and intellectual property, potential delays in regulatory approvals, the availability of funding sufficient for its foreseeable and unforeseeable operating expenses and capital expenditure requirements, the Company&#8217;s recurring losses from operations and negative cash flows, substantial fluctuation in the price of the Company&#8217;s common stock, risks related to geopolitical conflicts and pandemics and other important factors discussed in the &#8220;Risk Factors&#8221; section of the Company&#8217;s most recent Annual Report on Form 10-K and subsequently filed Quarterly Reports on Form 10-Q, and in other filings that the Company makes with the Securities and Exchange Commission. In addition, any forward-looking statements included in this press release represent the Company&#8217;s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company specifically disclaims any intention to update any forward-looking statements included in this press release, except as required by law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Investor Contact</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ron Moldaver</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Senior Director, Investor Relations &#38; Business Development</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ron.moldaver&#64;cartesiantx.com</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Media Contact</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">David Rosen</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Argot Partners</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cartesian&#64;argotpartners.com </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>rnac-20240522.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:91e8fb68-b1c6-4cbe-975b-d4c9e7616946,g:a1fed2b6-6cbb-4849-98a6-a76e3179c4d7-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rnac="http://www.cartesiantherapeutics.com/20240522" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cartesiantherapeutics.com/20240522">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rnac-20240522_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rnac-20240522_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPageDocument" roleURI="http://www.cartesiantherapeutics.com/role/CoverPageDocument">
        <link:definition>0000001 - Document - Cover Page Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>rnac-20240522_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:91e8fb68-b1c6-4cbe-975b-d4c9e7616946,g:a1fed2b6-6cbb-4849-98a6-a76e3179c4d7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_f4296a23-6bda-4582-9d61-74f49e6ae9cb_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a278db6e-3033-4f28-a2d3-acdae420202a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_46a03600-a545-4d1f-8cfa-3589a2422825_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_98125ff9-711f-48ed-9307-ace46958324e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_a59ee83f-560c-4288-b802-d051361275a7_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_cb1e5caa-8f88-4669-9a3b-dc795da50266_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_ac967473-56d1-46e5-ae28-d6e7c59aeae2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_17d62747-fe37-4a06-b345-7a69f57745b6_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_ab596bd0-10c8-41c1-814d-e51ebf1c7081_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_ab5bbde2-849d-43f8-8bd6-375e627652ff_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_38fad990-2452-4cb2-954a-d1c92cd7fee3_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_c67b2f0f-8e19-4380-b59b-cab9889736cb_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_263ef300-57e7-47a9-b96b-ab37712c6878_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_92ba4429-a5f2-48ad-a40b-c991769ab579_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_aa9288de-f01f-4bef-a389-34ee04fcee32_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_66a7e58f-fee3-4e82-ae82-f730298c5f62_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_81abf36a-8b9c-4180-bc1f-40f27a900599_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3adfa4f9-bfb5-46d5-bc47-84df08352e86_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_8dccfb47-c2b3-44ed-8463-ae65afc3dba4_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1b3ef560-29c9-4e9a-962f-f0e7b2e2ebcc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_6c4accb3-b56a-4f6d-9d3a-31a51b8d3af5_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_f03f750b-e60b-4d9d-9d44-938b31350562_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_46826109-cd11-45b4-8612-a791f6697880_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_2b98ac2d-c260-4fd3-982b-e2e4d690d17f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>rnac-20240522_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:91e8fb68-b1c6-4cbe-975b-d4c9e7616946,g:a1fed2b6-6cbb-4849-98a6-a76e3179c4d7-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/CoverPageDocument" xlink:type="simple" xlink:href="rnac-20240522.xsd#CoverPageDocument"/>
  <link:presentationLink xlink:role="http://www.cartesiantherapeutics.com/role/CoverPageDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_b4874593-b636-4b7f-99f3-e9f8177d73fb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_DocumentType_b4874593-b636-4b7f-99f3-e9f8177d73fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_6cd6c8ba-b17c-4bf3-ae95-a045c9b29364" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_DocumentPeriodEndDate_6cd6c8ba-b17c-4bf3-ae95-a045c9b29364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d47c9367-75ff-4925-b51b-8e464d19fd9a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_EntityRegistrantName_d47c9367-75ff-4925-b51b-8e464d19fd9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0e3199e7-99b4-4d70-83cb-0c724c0c30a2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0e3199e7-99b4-4d70-83cb-0c724c0c30a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_25d89ec0-31a1-4403-a6d6-5867adc0e072" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_EntityFileNumber_25d89ec0-31a1-4403-a6d6-5867adc0e072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_927faabe-245e-4d7e-8478-7724af0d14bb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_EntityTaxIdentificationNumber_927faabe-245e-4d7e-8478-7724af0d14bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f3dbe42e-1690-498b-ac77-86a2def2ed22" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_EntityAddressAddressLine1_f3dbe42e-1690-498b-ac77-86a2def2ed22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_d505d520-7acb-4b43-8c5d-60cd27aa7a18" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_EntityAddressCityOrTown_d505d520-7acb-4b43-8c5d-60cd27aa7a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_8955a559-5774-47e2-bc05-005d5b831fee" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_EntityAddressStateOrProvince_8955a559-5774-47e2-bc05-005d5b831fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_959525dd-de0b-43a6-b5ad-fd4639a9b6f2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_EntityAddressPostalZipCode_959525dd-de0b-43a6-b5ad-fd4639a9b6f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_13191f5b-027f-401f-8095-e8ea73b4e162" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_CityAreaCode_13191f5b-027f-401f-8095-e8ea73b4e162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_99ffdd2f-724e-41cb-8f0d-c1dbe1d2db43" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_LocalPhoneNumber_99ffdd2f-724e-41cb-8f0d-c1dbe1d2db43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_408b0de9-ec73-4a26-b740-27b45dccff55" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_WrittenCommunications_408b0de9-ec73-4a26-b740-27b45dccff55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_3c9dea7e-9168-41b1-a76f-d33a25451853" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_SolicitingMaterial_3c9dea7e-9168-41b1-a76f-d33a25451853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_1d233e8a-0056-4ac8-b1fd-eab4fe0a2f43" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_PreCommencementTenderOffer_1d233e8a-0056-4ac8-b1fd-eab4fe0a2f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_dc4ff72e-a48e-4ed6-932d-e9d767d3b87e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_dc4ff72e-a48e-4ed6-932d-e9d767d3b87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_db159552-cc60-4a3a-b83b-e5b27b5821ee" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_Security12bTitle_db159552-cc60-4a3a-b83b-e5b27b5821ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8db3ded4-f50e-4f5e-acc5-c779de1ce493" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_TradingSymbol_8db3ded4-f50e-4f5e-acc5-c779de1ce493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_577d97e3-b4eb-42e5-91b2-65a848b0cfec" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_SecurityExchangeName_577d97e3-b4eb-42e5-91b2-65a848b0cfec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_abef5b91-6c98-460a-b784-bb03a2712e25" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_EntityEmergingGrowthCompany_abef5b91-6c98-460a-b784-bb03a2712e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_c2d60756-6e69-4ec9-8405-1d4a8a5b9207" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_EntityCentralIndexKey_c2d60756-6e69-4ec9-8405-1d4a8a5b9207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_df1375f0-31e7-4b46-9583-bd7f74728afd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_AmendmentFlag_df1375f0-31e7-4b46-9583-bd7f74728afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_dc9236a5-5cd6-4e46-a2d0-830e888168a5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d0a23704-5323-4142-8745-0a7d78682260" xlink:to="loc_dei_CurrentFiscalYearEndDate_dc9236a5-5cd6-4e46-a2d0-830e888168a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
MB5!.1PT*&@H    -24A$4@  !U    (\" 8   !/@SDF   *J6E#0U!)0T,@
M4')O9FEL90  2(F5EP=4$]D:Q^],>J,%0H?0>V\!I-=0!.D@*B$!$DH(@2!@
M0V51P;6@(@**H*L@"JY*$1LBBFU1;-@79!%05[$@*FIVD$=X^]YY[YWW/^<[
M\SO?W/G?;^[<>\XW ) OLP2"=%@&@ Q^CC#,SY,>$QM'QST#$"  '("!)HN=
M+? (#0T"B&:O?]?'>\AH1+?-IKW^_?Y_E2PG*9L- !2*<"(GFYV!\ DDCK(%
MPAP 4!PDK[,T1S#-ZQ&6%R(%(EP]S2DS?'2:$V>X^\>8B# OA.\#@">S6,(4
M $A_('EZ+CL%\2&C$;;D<WA\A&T1=F5S6<@\9.0>,,W(R)SFO0@;)OZ33\K?
M/!,EGBQ6BH1GWN6'\-Z\;$$Z*___7([_K8QTT>P<VDB0N4+_L.GYD#6K3\L,
ME# _<7[(+/,X,S5-,U?D'SG+[&RON%GFL+P#9UF4%NDQRRSAW+.\'&;$+ LS
MPR3^_/3Y01+_)*:$D[)]PF<YF>?+G.4";D3T+.?RHN;/<G9:>.#<&"])7B@*
MD]2<+/25O&-&]EQM;-;<7#G<"/^Y&F(D]7"2O'TD>7ZD9+P@QU/B*4@/G:L_
MW4^2S\X-ESR;@VRP64YE!83.^81*U@?P0#!@ 79.4M[TO@)>F8)\(2^%FT/W
M0$Y)$IW)9YN;TJTMK1@ 3)^YF4_ZGO;C+$&TJW.YM>L <&D0B\6GYG*!PP <
M?P, \<E<SB 5 "DN )=WL$7"W)G<]%8'&$ $TD >* ,-H ,,@1FP!O; &;@#
M'Q  0D $B 6+ 1MP0080@J5@.5@-BD$IV )V@$I0 _:!>G $' -MX#0X#RZ!
M:^ FN L>@0$P#%Z"<? 13$$0A(,H$!52AC0A/<@$LH88D"OD P5!85 LE "E
M0'Q(!"V'UD*E4!E4"=5"#="OT$GH/'0%ZH,>0(/0&/0.^@*C8#(L#ZO#^K %
MS( ]X$ X EX$I\!9< %<!&^"*^ Z^##<"I^'K\%WX0'X)3R! B@2BH;20IFA
M&"@O5 @J#I6,$J)6HDI0Y:@Z5!.J ]6#NHT:0+U"?49CT50T'6V&=D;[HR/1
M;'06>B5Z([H278]N17>C;Z,'T>/H[Q@*1@UC@G'",#$QF!3,4DPQIAQS -."
MN8BYBQG&?,1BL32L =8!ZX^-Q:9BEV$W8G=CF[&=V#[L$'8"A\,IXTQP+K@0
M' N7@RO&[<(=QIW#W<(-XS[A27A-O#7>%Q^'Y^/7X,OQA_!G\;?P(_@I@@Q!
MC^!$""%P"/F$S83]A ["#<(P88HH2S0@NA CB*G$U<0*8A/Q(O$Q\3V)1-(F
M.9(6D'BD0E(%Z2CI,FF0])DL1S8F>Y'CR2+R)O)!<B?Y ?D]A4+1I[A3XB@Y
ME$V4!LH%RE/*)RFJE+D44XHCM4JJ2JI5ZI;4:VF"M)ZTA_1BZ0+I<NGCTC>D
M7\D09/1EO&18,BMEJF1.RO3+3,A29:UD0V0S9#?*'I*](CLJAY/3E_.1X\@5
MR>V3NR W1$51=:A>5#9U+74_]2)U6!XK;R#/E$^5+Y4_(M\K/ZX@IV"K$*60
MIU"E<$9A@(:BZ=.8M'3:9MHQVCW:%T5U10_%),4-BDV*MQ0GE525W)62E$J4
MFI7N*GU1IBO[**<I;U5N4WZB@E8Q5EF@LE1EC\I%E5>J\JK.JFS5$M5CJ@_5
M8#5CM3"U96K[U*ZK3:AKJ/NI"]1WJ5]0?Z5!TW#72-78KG%68TR3JNFJR=/<
MKGE.\P5=@>Y!3Z=7T+OIXUIJ6OY:(JU:K5ZM*6T#[4CM-=K-VD]TB#H,G62=
M[3I=.N.ZFKK!NLMU&W4?ZA'T&'I<O9UZ/7J3^@;ZT?KK]-OT1PV4#)@&!0:-
M!H\-*89NAEF&=89WC+!&#*,TH]U&-XUA8SMCKG&5\0T3V,3>A&>RVZ3/%&/J
M:,HWK3/M-R.;>9CEFC6:#9K3S(/,UYBWF;^VT+6(L]AJT6/QW=+.,MURO^4C
M*SFK *LU5AU6[ZR-K=G65=9W;"@VOC:K;-IMWMJ:V";9[K&];T>U"[9;9]=E
M]\W>P5YHWV0_YJ#KD.!0[=#/D&>$,C8R+CMB'#T=5SF>=OSL9.^4XW3,Z8VS
MF7.:\R'GT7D&\Y+F[9\WY*+MPG*I=1EPI;LFN.YU'7#3<F.YU;D]<]=QY[@?
M<!_Q,/)(]3CL\=K3TE/HV>(YZ>7DM<*KTQOE[>==XMWK(^<3Z5/I\]17VS?%
MM]%WW,_.;YE?IS_&/]!_JW\_4YW)9C8PQP,< E8$= >2 \,#*P.?!1D'"8,Z
M@N'@@.!MP8_GZ\WGSV\+ 2',D&TA3T(-0K-"3RW +@A=4+7@>9A5V/*PGG!J
M^)+P0^$?(SPC-D<\BC2,%$5V14E'Q4<U1$U&>T>710_$6,2LB+D6JQ++BVV/
MP\5%Q1V(FUCHLW#'PN%XN_CB^'N+#!;E+;JR6&5Q^N(S2Z27L)8<3\ D1"<<
M2OC*"F'5L282F8G5B>-L+_9.]DN..V<[9RS)):DL:239);DL>33%)65;RAC7
MC5O.?<7SXE7RWJ;ZI]:D3J:%I!U,$Z='IS=GX#,2,D[RY?AI_.Y,C<R\S#Z!
MB:!8,)#EE+4C:UP8*#R0#64ORF[/D4>:F^LB0]%/HL%<U]RJW$]+HY8>SY/-
MX^==SS?.WY _4N!;\,LR]#+VLJ[E6LM7+Q]<X;&B=B6T,G%EURJ=546KA@O]
M"NM7$U>GK?YMC>6:LC4?UD:O[2A2+RHL&OK)[Z?&8JEB87'_.N=U->O1ZWGK
M>S?8;-BUX7L)I^1JJ65I>>G7C>R-5W^V^KGB9_&FY$V]F^TW[]F"W<+?<F^K
MV];Z,MFR@K*A;<';6K?3MY=L_[!CR8XKY;;E-3N).T4[!RJ"*MIWZ>[:LNMK
M);?R;I5G57.U6O6&ZLG=G-VW]KCO::I1KRFM^;*7M_=^K5]M:YU^7?D^[+[<
M?<_W1^WO^87Q2\,!E0.E![X=Y!\<J ^K[VYP:&@XI'9H<R/<*&H<.QQ_^.81
M[R/M369-M<VTYM*CX*CHZ(M?$WZ]=RSP6-=QQO&F$WHGJENH+26M4&M^ZW@;
MMVV@/;:][V3 R:X.YXZ64^:G#I[6.EUU1N',YK/$LT5GQ><*SDUT"CI?G4\Y
M/]2UI.O1A9@+=[H7=/=>#+QX^9+OI0L]'CWG+KM</GW%Z<K)JXRK;=?LK[5>
MM[O>\IO=;RV]]KVM-QQNM-]TO-G1-Z_O["VW6^=O>]^^=(=YY]K=^7?[[D7>
MN]\?WS]PGW-_]$'Z@[</<Q]./2I\C'E<\D3F2?E3M:=UOQO]WCQ@/W!FT'OP
M^K/P9X^&V$,O_\C^X^MPT7/*\_(1S9&&4>O1TV.^8S=?+'PQ_%+P<NI5\9^R
M?U:_-GQ]XHW[F^OC,>/#;X5OQ>\VOE=^?_"#[8>NB=")IQ\S/DY-EGQ2_E3_
MF?&YYTOTEY&II5]Q7RN^&7WK^![X_;$X0RP6L(2L'ZT "@DX.1F =P<!H,0"
M0+V)] ]2,SWQ#T$S??P/ O^)9_KF'[('H FY3+="7IT '$5"WQWQ+@1@NB6*
M< >PC8TD_J'L9!OK&2\RTEEB/HG%[]4!P'4 \$TH%D_M%HN_[4>*?0! 9]9,
M+SXM+/*'TH0K3.HNZ^NP* 3_HK\ @54&"^N<;*T    )<$A9<P  %B4  !8E
M 4E2)/    &>:518=%A-3#IC;VTN861O8F4N>&UP       \>#IX;7!M971A
M('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)835 @0V]R92 U
M+C0N,"(^"B @(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO
M<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S
M8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.F5X:68]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO97AI9B\Q+C O(CX*(" @(" @(" @/&5X
M:68Z4&EX96Q81&EM96YS:6]N/C$X-S(\+V5X:68Z4&EX96Q81&EM96YS:6]N
M/@H@(" @(" @(" \97AI9CI0:7AE;%E$:6UE;G-I;VX^-3<R/"]E>&EF.E!I
M>&5L641I;65N<VEO;CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(#PO
M<F1F.E)$1CX*/"]X.GAM<&UE=&$^"D@&QWX    <:41/5     (        !
M'@   "@   $>   !'@  LAHV]UW$  !  $E$051X >S==X!<9;W_\>^VV5Z2
MW623;!IIA!ZZ@$ H5Q$N7D 4$,&"@G!11.Y/Q$N1HBB*(!=%I DQTHN"&)42
M>@DAH24A#=+;;K;WDM_W^\R<L[.;+9-D=F=VYGVNLZ?.<Y[S.OM'+I_]/D_*
M-EV$!0$$$$   0000  !!!!   $$$$   0000  !!!!   $$$$! 4@A0^2U
M  $$$$   0000  !!!!   $$$$   0000  !!!!   $$@@($J/PF((   @@@
M@  """"   ((((   @@@@  """"   ((((   B$! E1^%1!   $$$$   000
M0  !!!!   $$$$   0000  !!!!  (&0  $JOPH(((   @@@@  """"   ((
M((   @@@@  """"   ((((! 2(  E5\%!!!   $$$$   0000  !!!!   $$
M$$   0000  !!!! ("1 @,JO @((((   @@@@  """"   ((((   @@@@  "
M"""   (((! 2($#E5P$!!!!   $$$$   0000  !!!!   $$$$   0000  !
M!! ("1"@\JN   ((((   @@@@  """"   ((((   @@@@  """"   ((A 0(
M4/E50  !!!!   $$$$   0000  !!!!   $$$$   0000  !!$("!*C\*B"
M  ((((   @@@@  """"   ((((   @@@@  """"   (A 0)4?A400  !!!!
M  $$$$   0000  !!!!   $$$$   0000 "!D  !*K\*"""   ((((   @@@
M@  """"   ((((   @@@@  """" 0$B  )5?!0000  !!!!   $$$$   000
M0  !!!!   $$$$   0000" D0(#*KP(""""   ((((   @@@@  """"   ((
M((   @@@@  """ 0$B! Y5<! 0000  !!!!   $$$$   0000  !!!!   $$
M$$   000" D0H/*K@  """"   ((((   @@@@  """"   *]"JPJ;^SU7/B)
MD\[[:?BN_/V>KOM=3O:P,Z$DNX>C'$(  0000  !! 9?@ !U\,VY(P((((
M @@@@  """"   ((((   D-&@ !UR+PJ.HH  @@@@  "41(@0(T2),T@@  "
M"""   ((((   @@@@  """"0B ($J(GX5GDF!!!   $$$.A+@ "U+QW.(8
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M4/O2X1P""""   ((((   @@@@  """"   ))+D" FN2_ #P^ @@@@  "22A
M@)J$+YU'1@ !!!!   $$$$   0000  !!!! (%(! M1(I;@. 0000  !!!)%
M@  U4=XDSX$  @@@@  """"   ((((   @@@@,  "!"@#@ J32*   ((((!
M7 L0H,;UZZ%S"""   ((((   @@@@  """"   ((Q%:  #6V_MP= 0000  !
M! 9?@ !U\,VY(P((((   @@@@  """"   ((((   D-&@ !UR+PJ.HH  @@@
M@  "41(@0(T2),T@@  """"   ((((   @@@@  """"0B ($J(GX5GDF!!!
M  $$$.A+@ "U+QW.(8   @@@@  """"   ((((   @@@D.0"!*A)_@O XR.
M  ((()"$ @2H2?C2>60$$$   0000  !!!!   $$$$   00B%2! C52*ZQ!
M  $$$$ @400(4!/E3?(<"""   ((((   @@@@  """"   ((#(   >H H-(D
M @@@@  "",2U  %J7+\>.H<  @@@@  """"   ((((   @@@@$!L!0A08^O/
MW1%   $$$$!@\ 4(4 ??G#LB@  """"   ((((   @@@@  """ P9 0(4(?,
MJZ*C"""   (((! E 0+4*$'2# ((((   @@@@  """"   ((((   HDH0(":
MB&^59T(  0000 "!O@0(4/O2X1P""""   ((((   @@@@  """"   ))+D"
MFN2_ #P^ @@@@  "22A @)J$+YU'1@ !!!!   $$$$   0000  !!!! (%(!
M M1(I;@. 0000  !!!)%@  U4=XDSX$  @@@@  """"   ((((   @@@@,
M"!"@#@ J32*   ((((! 7 L0H,;UZZ%S"""   ((((   @@@@  """"   ((
MQ%:  #6V_MP= 0000  !! 9?@ !U\,VY(P((((   @@@@  """"   ((((
M D-&@ !UR+PJ.HH  @@@@  "41(@0(T2),T@@  """"   ((((   @@@@  "
M"""0B ($J(GX5GDF!!!   $$$.A+@ "U+QW.(8   @@@@  """"   ((((
M @@@D.0"!*A)_@O XR.   ((()"$ @2H2?C2>60$$$   0000  !!!!   $$
M$$   00B%2! C52*ZQ!   $$$$ @400(4!/E3?(<"""   ((((   @@@@  "
M"""   ((#(   >H H-(D @@@@  "",2U  %J7+\>.H<  @@@@  """"   ((
M((   @@@@$!L!0A08^O/W1%   $$$$!@\ 4(4 ??G#LB@  """"   ((((
M @@@@  """ P9 0(4(?,JZ*C"""   (((! E 0+4*$'2# ((((   @@@@  "
M"""   ((((   HDH0(":B&^59T(  0000 "!O@0(4/O2X1P""""   ((((
M @@@@  """"   ))+D" FN2_ #P^ @@@@  "22A @)J$+YU'1@ !!!!   $$
M$$   0000  !!!! (%(! M1(I;@. 0000  !!!)%@  U4=XDSX$  @@@@  "
M"""   ((((   @@@@,  "!"@#@ J32*   ((((! 7 L0H,;UZZ%S"""   ((
M((   @@@@  """"   ((Q%:  #6V_MP= 0000  !! 9?@ !U\,VY(P((((
M @@@@  """"   ((((   D-&@ !UR+PJ.HH  @@@@  "41(@0(T2),T@@  "
M"""   ((((   @@@@  """"0B ($J(GX5GDF!!!   $$$.A+@ "U+QW.(8
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M4/O2X1P""""   ((((   @@@@  """"   ))+D" FN2_ #P^ @@@@  "22A
M@)J$+YU'1@ !!!!   $$$$   0000  !!!! (%(! M1(I;@. 0000  !!!)%
M@  U4=XDSX$  @@@@  """"   ((((   @@@@,  "!"@#@ J32*   ((((!
M7 L0H,;UZZ%S"""   ((((   @@@@  """"   ((Q%:  #6V_MP= 0000  !
M! 9?@ !U\,VY(P((((   @@@@  """"   ((((   D-&@ !UR+PJ.HH  @@@
M@  "41(@0(T2),T@@  """"   ((((   @@@@  """"0B ($J(GX5GDF!!!
M  $$$.A+@ "U+QW.(8   @@@@  """"   ((((   @@@D.0"!*A)_@O XR.
M  ((()"$ @2H2?C2>60$$$   0000  !!!!   $$$$   00B%2! C52*ZQ!
M  $$$$ @400(4!/E3?(<"""   ((((   @@@@  """"   ((#(   >H H-(D
M @@@@  "",2U  %J7+\>.H<  @@@@  """"   ((((   @@@@$!L!0A08^O/
MW1%   $$$$!@\ 4(4 ??G#LB@  """"   ((((   @@@@  """ P9 0(4(?,
MJZ*C"""   (((! E 0+4*$'2# ((((   @@@@  """"   ((((   HDH0(":
MB&^59T(  0000 "!O@0(4/O2X1P""""   ((((   @@@@  """"   ))+D"
MFN2_ #P^ @@@@  "22A @)J$+YU'1@ !!!!   $$$$   0000  !!!! (%(!
M M1(I;@. 0000  !!!)%@  U4=XDSX$  @@@@  """"   ((((   @@@@,
M"!"@#@ J32*   ((((! 7 L0H,;UZZ%S"""   ((((   @@@@  """"   ((
MQ%:  #6V_MP= 0000  !! 9?@ !U\,VY(P((((   @@@@  """"   ((((
M D-&@ !UR+PJ.HH  @@@@  "41(@0(T2),T@@  """"   ((((   @@@@  "
M"""0B ($J(GX5GDF!!!   $$$.A+@ "U+QW.(8   @@@@  """"   ((((
M @@@D.0"!*A)_@O XR.   ((()"$ @2H2?C2>60$$$   0000  !!!!   $$
M$$   00B%2! C52*ZQ!   $$$$ @400(4!/E3?(<"""   ((((   @@@@  "
M"""   ((#(   >H H-(D @@@@  "",2U  %J7+\>.H<  @@@@  """"   ((
M((   @@@@$!L!0A08^O/W1%   $$$$!@\ 4(4 ??G#LB@  """"   ((((
M @@@@  """ P9 0(4(?,JZ*C"""   (((! E 0+4*$'2# ((((   @@@@  "
M"""   ((((   HDH$&F ^L7SKY,4_3]O^=L?KY)MWDX$ZPDEV1%<Q24(((
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M'YS;XZ/\X*R9<MS!T_H=QI< M4<^#B*   ((((! # 0(4&. SBT10  !!!!
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MY!O^XP2R<MQV2U.#?^S;IQXF_W7D/OXPOLT:GC;JIZ6MPP6HEKT2H/I<;""
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MJGUML6%[_W3-V3&M]O61V$   0000 "!F H0H,:4GYLC@  """"   ((((
M @@@@  """#0N\ #?W];'GU^89<++,2<>=!45RDY=D11EW,#L5/3V.;F0$U/
M2Q6]M;ST[G+Y]9]?\&^5FAZ0LJG[2TJ*GNQAV;9MFZQ;MD ZVEK\L__O:\?*
M40=,Z3*,;T%VNG]^H#;6;JF2Q]1S[CO+7'@;?I^O'#]#SCGQD/!#;".   ((
M((! D@H0H";IB^>Q$4   0000  !!!!   $$$$   03B7Z"ZODF^==ULOTHR
MO,>65QZVSV[RE?_87R:7E82?BNIV?7.[9*:GNNI3N^>U=\^1=Q:M]N^17SQ:
MAI5.\/=[VJC<]*G45FST3QVTYWBYYMLG=!G&-S=SX.8=7;ZV7!Y];H&\\<$G
M[IY^1T(;5MU[W]5?DX+<V,W#VKU/[".   ((((! [ 0(4&-GSYT10  !!!!
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MO^WWSCA*/G?H='^?#0000  !!!! H"<! M2>5#B&  ((((   @@@@  """"
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M1^S59XB:G5<D-O^IMV1E9LC]UYPM.5D![Q!K!!!   $$$$"@3P$"U#YY.(D
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MZ[N'J%M6?ZS=[CQ:4I0KM_W/ER4_)]!CB&IA[Q]_<J:4ZA_*LR"   ((((
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M.+%0=6]=6^5J05[VX'4BB>^TJKQS#IDD9N#1$4   0000  !!!!   $$=D%
MBS>[!)$NT+1@4P-*"RG#/[KK]H/?Z9QSM/OMFUK:Y)QK9DE3<ZM_:MBHB9(_
M?)2_[X6?6GCJJD^S=7C>7!VVMU"K3H?G94BQ!:BZMGV;"]7F1+60U56>6O]"
M'7?M^*UVW7!5J';(JE!#U:@6BEHXVA2J0JW6ZM/*NE:IT !UJZYMO]Z&\]5A
M?JT*5?^W715J[=:-4KGQ4_]F]H?GLZX]1_O8\[1(+LC53M@Z&,IVSLWJ!;L=
MVB\MD'7]=-?K#]=_^\&"  ((((# $!"84$(N$(W71( :#<48M/'^XM5RUU^>
MEX=T#HO:^J88](!;#@6!"6-+9)_IX_5CH6IP/7E"*<, 1_GE$:!&&93F$$
M 0000  !!!!  ($D$8@T-'4A:BBL=-_1'\'@LQ-JY?H*J:BJEX/W'.\??'[>
M4KGUP;G^?FI:AI1-W;_'ZM-T'8[7@E$+20LT++6JTY+\@ S7CVU;]:D-ZVO7
MV+5=YSRUWN@26@5WPGZ&PD<715HXJ:<LJ&P+#>5KP_7:,+Y6@;JUMD7*]6/;
M-1:BAJI0[=J>JE#7+5L@'>V= ?&E7YTIQQXTS;_YO$6KI;@H5R:-*?:/!8/4
M4"!K_=$#+C2U\#3L0YCJD[&!  (((#"$! A0H_.R"%"CXS@HK=A<#\^^L%!N
MN>M9>?7M)8-R3VZ2> +960'9<VJ9[+OG!/G, 5/T,U6F31KMAMI)O*<=G"<B
M0!T<9^Z"  ((((   @@@@  """2*0# X#5:.>I6<X16F[IA5G6H@:16>O86F
MFRMK9>[\Y?I9)FLV5<GQA^PNEYQYM,_TOW?\7=Y?UCE/:$')&"D:V1FP6MYI
M0^]V5I^FN:"T*!2>%FMX6NQ5GVI5JC=TKPM/@P_A[M5;;NIW)+01RE$[*U$U
MK+3Y4&TH7ZLVM:K3"JM"#86H51JB6K!J<Z7V5H5:M7FUU)2O]V^UK_XWCY]=
M>)*__]N'7I+GWOY8QI46R<P#I^IGBHP<EN^?CS1,#:]8#7XG6,GJ-\0& @@@
M@  "<2) @!J=%T& &AW' 6VEL:E%_O+D:W+;O7/DXQ6=_R <T)O2>%()Y&0'
M9,+8$3*AK$0FCM.U;MMZHAW3*M;A17E)Y;&C#TN NJ-B7(\  @@@@  """"
M  (())^ ES=Z<X5Z<XZF:U!J%9V1AJ:U.IW3J^^MD!?F+9,EGV[J AD>H%;K
MB&7G7/V &Z[6NVCTY/TD([-S6#\OF+4^9.J\IC;WJ0W5:Z%I24%FL )5M]W<
MIUV&[M7(-/@_K^D=6KL@U:O\U!#5AO*UD-3"4AN^URI0RVN:79AJH:K-A=JL
M(6N;7FL%!A9@>DMK<Z-L6/&>M^O"YEG7G2N%N5GNF!>@^A?HQO2)I7+LP5/E
ML_M-EOR<3/]4?V&J5<%:'X)A:K ?KC_:0GB?_ ;90  !!!! ( 8"!*C102=
MC8[C@+12H7]%>,<#S^GGWV+;+ C$2L"J5DN&Y\N(X0524ISOMD<6Z[;NCW#[
MNM;S)7ILA'[R0_]/2JSZ.]CW)4 =;''NAP """"   ((((   @@,#8$>0U,-
M'KUY32TXM? R6(7:>Z5I<VN[O/7!)_+BN\MEP9(U+L#K22 \0'UEX0JYZ8'G
M_<L"6;DR:M(^_KZK&K6^:"<S=%A>JR[-URI3F^_4*D]'A )4JT9U<Y_J^72]
M3KOKJE;=]_W6=GS#,E +'S6/E#:;"]6J4#4HM:I3"U"W6("J:YL7M5:K4^U\
MJU[7?1A?N_/&E1](2U.]WXD?G7N<'#ECLMOO*4#U+C3W_77:HV-TA*Y#]]E-
M0^0T[Y0+1+T^6CCJAOG5SEJ :D&J"U$M3 V=<^&K_@A^QV^&#0000  !! 9=
M@  U.N0$J-%QC&HK:W3."ANF]T^/S)6&QI:HMDUC" R&0" C78H*<[5R-5?F
M/G:-%!7D#,9M8W8/ M28T7-C!!!   $$$$   0000"#N!/H+32VT\SX61MIV
M\#O!M?= '1T=LG#Y>GGIG67RVON?2'-+FW>JUW5X@'K[HR_+/]_HG *JH'BT
M%)5.\+]K :@W?*_-:YJM%:8V]ZE5GUIX.J)0YS_-"VA%:KH[Y^8^M;[:QV]E
MUS9<V!@*);TJU.H&JT+5 +4Z%*)J@&ISH5J%JEW3KA.H>E6?WMVK-JV2FHH-
MWJY\_K#I<O&7CW+[?06H_A=T(S.0+D?LNYL<?=!4F3%EC(;<J?YI%XYJ-&KK
M\*%\;=O[,%^JS\4& @@@@$",!0A0H_,""%"CXQB55I9_NE%N^OW3\N!3K^E?
MU+5'I4T:02#6 FOF_<Y5I<:Z'P-Y?P+4@=2E;0000  !!!!   $$$$ @_@4B
M#4U=Y:FFCWW-:[ILS19YX9VE\LJ"%5)=U[1##Q\>H%[XBX=E[>9J__LCQD^7
M[+PB?]\%J!J&6@6LA:.Y66DR3*M-K?ITI 6H!0&M1@VXX7N#<Y^FNK!W5X;N
M]6\>VK  U4HV+81LU634JDQM&-]*"U!K6F2S5X6J5:GU3<$ U0WCJ]>[[X;:
M::RKDBVK.\/BL2,+Y8X?G^'.1AJ@AIIRJ\*\+#ER_\ER[$'39*I.<>0MP2 U
M%.!J!UQ5JJW#@E07L-I^Z+S[COZP_MHV"P((((   @,M0( :'6$"U.@X[E(K
M2U=ND!O_[REYY)DWI=W^C(X%@0026/76[5(ZHC"!GFC[1R% W=Z$(P@@@  "
M"""   ((((! ,@@$JSB]2LX4-[RM5UWJK2,)3=>75\O<^<OEQ?E+96-Y_],X
M902R):>PV%5BUI2O\ZF] +5#__O2J9??XX(][^38Z0=K567G$+46^EJ0:\,(
M9^G0M7D6H&I@:L&I!:@E%J!JH)JGP_K:_*CV/%[PZ[49C;6%BM[PN#;/:9T.
MUUMIP_B& E0+4BU0K=, M4F',K;A<^WZ\#"RHZ-=UBZ9YW?'S)_\Y7F2FI8J
MW0/4@I(R5WG;4%TAK2V-_G=ZVQA=4B S#YRJGRDRIJ3SOV_8_8.A:+ OO86I
M+E#5"VWMS=]JWV-!  $$$$!@H 0(4*,C2X :'<>=:F7EZLURPV^?D(?^^GJ7
M?]#N5&-Q_B4;RG5\68F,&E$D^7G9DJ=S9-H\F>';>?K7?7DYP>-Y>HT[K]?8
M=KK^@[=1AS-N:&J6^@;]-#:[?=MN:-+C=LQM-TM5=;VLVU@IZS=5ZGJKK-?M
MZMJ&.!=*W.ZM?/TV&3-J6.(^H#X9 6I"OUX>#@$$$$   0000  !!!#H42 8
MGMIPO.+^NX55<EH8Z8)&W=9-/W"TH7*]L-5KK$JK2U]>L%R#TV6R;/46[W"O
MZ]3T@.06#M?/"+'Y3&VIJ]PL6S>L]+_C!:AKMU3)A3<^XA^W[XZ==H"_;QM>
M@&K5IU9A:L/W#M?A>UWUJ0[?6Y*?Z8;OS=4 -6#/I1_O.;HTM(L[7@C9KL%H
MBW[J-4"U87S+:YO=,+Y6A;HU-(RO5:C:,+[= U3KPMJE[TI'6^=46'^XX@PI
MTS_H[AZ@#A\]2?*&C72]MGE3ZZNWZ&=KE^_V]DA3QX]P8>I1^T^1(OWO6-[2
M7YAJH6]P[M2>AR#VVF&-  ((((! - 0(4*.AJ/]6TK]\XH^>HF,9<2L;--C[
MF5:<_NGAE_2OYA)GJ-[<G$R9NMLH_8P.K4?)E-!^K.? K-10=?DG&\6J?;W/
MQRO6R\>Z3]5OQ+^Z.W7ALE=OE7%CBG?JNT/E2P2H0^5-T4\$$$   0000  !
M!!! ('H"%D!::)JA 62F?BP\M7VO2M,+&^TZ;VG2>4Q?>V^ES'UWN;R_=)T+
M KUS/:U3M&(TMV"X5IN62&9.@0LPPZ_K+4!]^Z/5<OT]<_Q+,W,+I'3"GOY^
M,,S5OFKXZ\U_:G.=NN%["S-=B&K;!=GIDI.9)AF:$MNUWC/Y#45APPM0=<I7
M-XQO0W.[U.@POA6UP2%\-U<WNVT+5;UY4.W:[O.@;EJU2)KK:_P>777>"7+(
M7N/[#%"]BZVMYH8:::@NE_J:K;)-*UK[6NP=[SNM3([1JM3#]YTD63I_JK?T
M%*8&PU.]AX:_K?IQPQ#S7V0],M8(((   E$6($"-#B@!:G0<(VJEIJY1;O[#
M,W+;O7.D4:LFA_*2GI8F^^\]00[:;[(<,F.R6T^96+K=/^3C_1FM:O7=#SZ1
MM_0O/M]>N-RM-VWIG!\DWOL_%/JW>.[-LMOXX%]V#H7^[DP?"5!W1HWO((
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M<P%JP 6G+D#5('587H96H*;[PQ.G6(7M#CI%>KD%J!:(>L/<UC:U265=JZM
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M O]X<:'\XG=_E;?>'1I#.^_L<_;VO3__W\5R^DF']G8Z(8X3H";$:^0A$$
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MNF4"]CMTW\-SY:>_>4S*M]8F-,J-5YSEJJ 3^2$)4!/Y[?)L"""   ((((
M @@@@,#."_07IEIX:7.GAH>37I6G?==;FEO;Y2T-45_4Z8$6+%GCPD;O7/@Z
M/$!]14? NNF!Y_W3-F_JJ$F=_[W(#>.K][;[6Q5JK@6H&IC:T+T6H-H\J!:H
MYH?F0;5A?*V?$OR?W^ZN;+AL47]8 &G#]]K\I[4Z_ZD%IA:<6O6I#=]K@6J]
M!JA6?6ISB=K0Q>&YY,:5'XC-9^HM/SKW.#ERQF2WVU> :L^S__1Q<LP!4^10
M#4\S-4CV%A>"ZHXW[*X7\@;G,@T&OE2:>EJL$4   03B28  -3IO@P U L>*
MREKYQJ5WR+]?_B""JV-S27I:F@NI_O>24R4K,R,VG>"N.RQ07=L@U_[F<;GS
MS\_%=3"_PP\6]H4K+SE-KM3?RT1>"% 3^>WR; @@@  """"   ((((! = 1Z
M#%-# :8%J2Y$U7W==$/KNNOUAPLZ[4=HJ6UHEI<U')W[SC)9\NDF[[!;AP>H
MU?5-<L[5#W2I@!P]>3^Q^5-M";9K]^V<!]6&\2W687Q'6("JP_@.UP#5YD:U
M.5(M9+6P-<4^KH5=_V$AJ(6A%DI:.&ISG-I<IULM0-7A>[=8@!H:OM>;_]3J
M&KPA<:T'K<V-LF'%>WYGS&W6=>=*86Z6.]93@#I]8JFK-#U*0]9\G0++6WH,
M3;63+BBU?FJ)J?4U6(5*I:GGQAH!!!! (+X$"%"C\SX(4/MQM/DJS_KOVV3M
MAJW]7!F[T_ON,5[^J/-,SMAK0NPZP9UW2>#=#S^1[UY^M[R_>/4NM1./7_[A
M^2?)SW]\9CQV+6I](D"-&B4-(8   @@@@  """"   ))(1 ,4X/#X0:K3\4%
MJ+;M?5(C"%,WZQ_]SYV_7#_+9,VF*@D/4 WR?^_XN[P?-H500<D8*1HYWAF[
M$%1_V#RH&:%Y4/-UN-YA&J!:%:J%J"6Z+M*JU-S,-#=/:KI>I]V*RERH+CS5
MQ%+S2&G3\-2J3^N;VZ7*AN_5JE,7GEKUJ0:HM3JLKYUO#<U_:N6G]GU;JC:O
MEIKR]<$=_;GOU#+YV84G^?M>@#JNM$AF'CA5/U-DY+!\_WQ_H6F787KUIK8?
M_$YP[3?$!@((((   G$B0( :G1=!@-J'X]U_>4%^>.TL:6GM?XZ)/IH9L%-I
M^B>"/[KP9/G)]T_5?^AV#C$R8#>DX0$5:&MOEYM^_[3\XO:_QNWOW,X V/RG
M-JQT(B\$J(G\=GDV!!!   $$$$   0000&#@!()!:BB0#(69K@(U+$B-M#)U
MQ;IRV5K=( ?O&0Q(K=?/SULJMSXXUW^ U+0,*9NZOU:1!N?W=/?7'U99:O.<
MYFA06ABJ0BT)!:C#-5"U87R]*M1@X&LI:K"*U6]\!S9<^*D_O&%QO>I3&[YW
MJP:F%J"6AZI/JQM:I4&#59L?U0W?J^FE!9BV;--Y8M<M6R =[:W! _KSTJ_.
ME&,/FN;OSUNT6HJ+<F72F&+_6*2A*4/T^F1L((   @@,(0$"U.B\+ +4'APM
M,+WDZOO=')4]G(Z+0[OI7*?WWW*A'++_E+CH#YV(GL '.I?)>9?](6&J4<\Z
MY0BY[S??C1Y0'+9$@!J'+X4N(8   @@@@  """"   )#3"#2,#488 8K5H/?
M"5:R]O2X32UM<LXULZ2IN3-@'#9JHN0/'^4NUPS459/:,+[I^L-"4@M+K>K4
MJD^M$M6&]+50-5>K4[,T9,W0A->J8ZURU1O+U]J)9 GEGJY\U,)3"RA;=5A<
M5WVJ5:86EMJ0O3;OJ86H5HUJH:H-W]NF8_=V'[ZW=NM&J=SXJ7]KF]9JUK7G
M2%8@W3\6OA$,3H,!;' 8WF!%:9<J4QNB-Q3NNNOUA_7;MED00  !!! 8"@($
MJ-%Y2P2HW1PWEU?+5[[[6WGSW67=SL3/[ADG'R:W__Q;DA^:RR%^>D9/HB5@
M(?ZUOWE,;KGK6??_3$2KW5BT<_)_'""/WGEI+&[-/1%   $$$$   0000  !
M!!!(>H'[GGY3GGCQ?=\A+3T@8Z;,<%6H+OC4'Q:&VCRL-L^I#==K<Z$."X6H
MPS5$M6T+5G.\N5"]$-5:=3EJ*$(-K?R;>1NA\-%%D19.ZG$+3VU.4:L^;="
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M<'GX#Y?(0?M.&M#[T'C\"514ULJW+KM3_JF_HT-Q.6#OW>3UOUTW%+M.GQ%
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MP7\ #NK-N5G<"3SWR@=RSO=_)Y75]7'7M]XZ-**X0-;,^UUOISF.  ((((
M @@@@  """"   )1%%BETP!=_,M'95)9L=QPX<E^B#IW_C*Y>?:+7>Y44#Q:
MBDHG^%6HP:%\4UPP:B%JMJM$#5:>%FB8:O.@YFH%:DX@53)UR-Q NLV=FMH9
MHEKKFJ!Z(:H%GE8UZLUY:N&I#<?;TK9-FG5(X08=GK<^5(%:HZ&I!:EU-FRO
MAJH6GEK0:M^Q -:K/JW:M$IJ*C98R_YRV=G'R,P#I[I]"T^OO.-I6;FN0FZ_
M_,LRH728?QT;"""   ((((! I ))&Z!:M>GWKOJ3W/M0UW\X1@HW&-?]]S<^
M)[^^ZFON+P$'XW[<8V@(K%R]V<W5NV3Y^B'189N[MWK)?4.BKW02 0000  !
M!!!   $$$$  @:$N<//L%V3N_.7N,;J'J-?>/4?>6;2ZRR,6ETV6W,(1?HCJ
M#>5KU:69&:ENSE.K.K7@-%>'];7*5 M6LT(!:D8H0 U6HEIXJO\72E"#N:=6
MGVJ":D%HL/HT&* V:8!J0:E5FM;K<+T6I%HUJLV)VMS:&9[:G*E>>%I?O44J
MUJWHTO^#]QPO5W_[!'<L/#RU S,/G"*7G7ULE^O900 !!!!   $$(A%(R@"U
MI;5-OO&#.^2)?[P=B5%,KKGRDE/ERDM.B\F]N6G\"U37-LA9%]TF+[SV4?QW
M5GM8M?A>JJB'Q)NBDP@@@  """"   ((((   D-98-/66CG_YP]UF?['0M2?
M772R#L<;$ L8O__K1Z6\*GQDJQ09,7YWR<XK<B&J5:%: &J!J(6H&5J)FA4*
M4K,U-,T.59]:N.J&\;4JU-!<J!:^>N&IYVCYIX6@KOK4AN_5ZE,;OM="4JM"
M;=0JU$9=6W#:9,%IE\K3SJ%[&^NJ9,OJC[59;3"TE!3ERFW_\V5795O7V"+_
M^_M@Y:EW/E7[]<>?G"FEP_.]0ZP10  !!!!  (&(!)(N0&UJ;I4S+_RMS)FK
M$\W'Z?+S'Y\I/SS_I#CM'=V*%X&V]G;Y[H_OD3\__DJ\=*G7?JQZZW8I'<$<
MOKT"<0(!!!!   $$$$   0000 "!* C<_NC+\L\WEFS74G@EZI)5F^2*VY]V
M0^EZ%Z:DI$K)N&D]AJA>D&IAJ?N$@M. 5IYFN"%\.P-4+WSUVK6U*R -"U#;
M=%A>%Z*ZH7RU&E5#4PM4[>,-V1L<MK=K>%J^9JFV98,!!Q<;.OC&BT^6Z1-*
M73#L#=OKG??6)QRVA_SWEX_T=EDC@  """"   (1"215@-K8U"*GGW^+//_J
MAQ'AQ.(B&[+WXF]^/A:WYIY#5."*&Q^46^YZ-JY[_]Z_?RF[3QX3UWVD<P@@
M@  """"   ((((   @@,98'*VD;YUG6SNP2CX<\37HGZRL(5\JM9S[MPL_.:
M%"DNF^0/Y^N%H5K$Z:I1+4BUT#)=JU*MXM2MW?"]P?->]:D-X>M*6:UA-_JN
MS6':686JN:GKHP6I;6Y.U."\J-X0OWK(#UVMUC0X;._*8&/6IBY6Y?JC<XZ7
MS\Z8U&=X:M=:G^^]^FP9EI]MNRP(((   @@@@$!$ DD3H%KEZ6G?OCFNASPE
M/(WH=Y:+>A"X\?:_RK6_>:R',_%QZ*7'KI%##Y@2'YVA%P@@@  """"   ((
M((   @@DH,"]?WM3GIS[?I]/%AZB/J/3 MWY^&O;75]0/%H*1XX7"T1=%FK#
M\NI5-ARN9J=N[<V3:N&J.ZX;=DWP*[;5N6A\&@Q$]9"%I!WVT634;6NR:ON:
MI;JU!:;;7,EJ,'"MWKQ::BHV=#86VKK@2T?(?QZQ5[_AJ??%TX[95[YY\F>\
M7=8(((   @@@@$"_ DD1H-J<IU9Y^J^7^OY'9+]: WC!C5><)9=^Y\0!O --
M)[K 37<\+5?_ZI&X?,PG[[E,OG#,C+CL&YU"  $$$$   0000  !!!! 8*@+
MV/R?W]3J4RL@\):BTO'26%LES0TUWB&W#A_.UT+4/S[QF@LXPR\*9.=)2=D4
MR0AD!0]K)NHJ4G7/0M/.ZM3@G*?!\#08G%J(&KY8'FJ+!:/!@#08CKJ<5']8
MF!H>G-JUK2U-4KYNN;0TUMFNOUC;YY_6=WB:F5,@V?E%4K5IM?^]K,P,N4^K
M4&T>6!8$$$   0000" 2@80/4&V>R+,NNDV>_O>[D7C$Y)HK+SE5KKSDM)C<
MFYLFEL O?O=7^>G-\5>)>N_-WY6OGGI$8F'S- @@@  """"   ((((   @C$
MB<"#_WQ7_O+/=_S>I*9E2-G4_:WV4[:L_KC'$/5G%YWL D4;SO<WLU_<?NA?
M32L+2\9(07&95IFF!MO6 -,;HM?+28-5IWI:-[QC?D="&RY##0M0[7#PF*U#
M":H>Z^CHT(K3=5)=OMX2U]"W@RL;BO>RLX_M<]A>"T]'C-_=]7'=L@72T=X9
M*'_U\P?)69\_H$N;[""   ((((   KT))'2 :D. ?//2.^3AI]_H[?EC?ORB
MKW].?G/-.3'O!QU('('K;WU"?G;;DW'U0 Q/'5>O@\X@@  """"   ((((
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MVZC58B0>/PVQ^^@>[NYX=G$1O_]V)\\!28 $2( $2( $2( $2( $2( $7)'
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M($V&S(I[WYSP](X[K_L!YQ$6_#BF6;FBN3"J<\.8:YZ0  F0  F0  F0@(Z
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M 1(@ 1(@ 1(@ 1(@ 1(@ 9<D,.Z7+3@0RXVN=ZJTR):O!$08?!IX.\[NRO@
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M:<:H=NC2IIZ63:1M)!"'P$>=IN(OY<>%+5.]ZJ6P8?$ 6P[!ODF !$B !$B
M!$B !$B !$B !$C )0D\>!R,3F-^A0B92241)44X?:=X[J2J&ET>$1FM[%YU
M4T14X.\#9_'C[WMCVGIZI42.0F5BKA,[N7/I)%Y$A,94Z?YQ-=6EL$PK,BH:
M7AYN,666GAP^&Z"Z'#Y_[?5NTX3Z%.%VP9"6R)PA34)5F$\")$ ")$ "))#,
M"#C-#M0@Y4'QG8:#-1_WM$SQO#CPYVB+5_8EL^\AI^M@ D&/@O%6PT$VC8=:
M\LW<./+W. ?/E,.3  F0  F0  F0  F0  F0  F0@/,1F+-F'_[:FW@XJW)%
M<^'3^N510A%0K9W"7D3#TSV%ND/T64@XV@Y;$D?,S5Z@E.(:-W6BPT:$/L?=
MJZ=CZHAHN734YTB;REOMZT742_AX6D] U0UTYLH=_&_+<9RX\'KGJZXL]K%Q
M]1+HTKQJ["R>DP )D  )D  ))&,"3B.@MNP^$VLW63=(O2WN^_:50U'E[2*V
MZ)I]DH!-">S8[X>&;2<H;G.27LUJCB&^&=/@]M&?S&G*-B1  B1  B1  B1
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M 1T^JVVK[MDO"3B4P&?=9N"/?XY8S8:6S:IBT=2N5NN/'9$ "9  "9  "9
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MH7,WXL2%FP;G6/;-7!C=I:&ZRU1BG8:+^UY%0)6C7/^GGU) -4B/F21  B1
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MX.CIJZCZP3"S)]?\O7?PZX^]S&[/AB1  B1  B1  HXCT&OH+YBW?%NB!E!
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M,7/A)J/FZILA-6X?FV-4758B 1(@ 1(@ 1)P#($+EV^C3/V!)@]. =5D9&Q
M B1  B1  IHGD)B *L:+B"K_U[KO)$4\]5#=^DK6+Y/ZRD$5444Y34P\E7H4
M4(4"$PF0  F0  F0@!8(V$5 E;BG$O_4V9+_WNG(G3.3LYE->TG (00D!FJ)
MVOW4U:3&&/#H[,](Z>-E3%76(0$2( $2( $2<  !4Q9'Q3:/ FIL&CPG 1(@
M 1(@ =<@D)2 JIMET\ZC%!U5E5/5K#_G#4U2--6UE2,%U-@T>$X")$ ")$ "
M).!( G814"LT&HQ3YP(<.4^3QRY>^ T<^^=[D]NQ 0DD9P)-OYB$S;M.&87
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M04DB63BE*UHUKYID/58@ 1(@ 1(@ 1*P/X$ZGXS&_B,7S1J8 JI9V-B(!$B
M!$B !#1-@ *JIF\/C2,!$B !$B !31"X>?,FMFS9HGZV;MVJ"JC&&I8Z=6K4
MJ%$#]>K50]VZ=5&Z=&FD2/$Z+("Q_5BSGDT%U*?!H<A7\2N$A$98TV:;]^7I
MX8Z[)^8B=2IOFX_% 4C U0B,GKX&8V>N37):H_I_@@'=FB19CQ5(@ 1(@ 1(
M@ 3L2^"L_RV4?_=;LP>E@&HV.C8D 1(@ 1(@ <T2H("JV5M#PTB !$B !$C
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M.M\217+AZ*;QB=9A(0F0  F0  F0@'T)6,.## 54^]XSCD8")$ ")$ "]B!
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M86VG#&N+'NT;.&Q\#DP"KD(@*BH:^2KUQ(.'3Q.<TN]S^Z!)_;<2+&<!"9
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MX<.'>OFF9%A%0)TR]R\,GO";*>-JJJZWEP>"_'Z&N[N;INRB,21  B1  B1
M B1  B1@+0)C9JS%F!EKK-5=@OU00$T0#0M(@ 1(@ 1(P&D)4$!UVEM'PTF
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M4)%1>18+J)%*D-?L9;HB."3,J &U6.G#]RM@Q>R>6C2--I$ "9  "9  "9
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MD( Y!#H-F(>EJ_:8T]2B-A10+<+'QB1  B1  B2@20(44#5Y6V@4"9  "9
M"5B%0$([4(<,&8+1HT<G.8:E JK$.Y5QFC1I8K)X*L95KEP9!P\>U+-STJ1)
MZ->OGUZ^L1D6":@!MP)1I'I?8\?29+V4/EYX=/9G3=I&HTB !$B !$B !$B
M!$C ' +_6W\ [7K_:$Y3B]M00+48(3L@ 1(@ 1(@ <T1H("JN5M"@TB !$B
M!$C :@02BH':HT</S)HU*\EQ+!50=0.\__[[6+9L&7Q]?7591AU+EBP)/S\_
MO;ISY\Y%Y\Z=]?*-S;!(0%V]\5^T_NH'8\?29+VBA7+BQ.8)FK2-1I$ "9
M"9  "9  "9" J03.^M]"C>8C$!P29FI3J]2G@&H5C.R$!$B !$B !#1%@ *J
MIFX'C2$!$B !$B !JQ+HT*$#%BU:I-=GLV;-L';M6KW\^!F)":@=.W9$X<*%
M$1P<C&O7KJD[12]=NA2_BYCK<N7*8??NW4B3)DU,7E(GF3)E0E!0D%ZU/__\
M4]W5JE=@9(9% NK@";]ARMR_C!Q*F]7>K54&ZQ::OX57F[.B521  B1  B1
M B2@70+1T2\1$A8.'V]/>+B[:]=0)[0LZ'$PJC4;CBL!]QUF/054AZ'GP"1
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M,ANNY.*Y\B.GQ^!%6/C;#LW,E *J9FX%#2$!$B !$B !JQ&@@&HUE.R(!$B
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M++%<5ZQ8$:>^N1=F":AW[CU"_LJ]S!U3,^W>*I4?^]:-THP]-(0$2( $[$E
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MW[:D;M^^[2V@ZMPN/GKZRLWB8\7UHKA=5(^2)^>*^\5/FU16?^_9EP9',X>
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M,V9$OW[](/%.TZ2QKP<QN6,F"Z@+?]N![HJK!E=(5Y079EKYLKD"3\Z!!$C
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MN?]/#+@LH)KE!"IQ\.;R3#X-]-.;@9\R \R O@SL.W(1E!9=I!8G9B1;[=-
M7EXBP?(8RZ0Y6]&DRS2/[7AB(+12$X_JRD:)%-83,SS610;H"XH(J9P=P?9+
M0*6_#U6:CE'2RCQQ--2I>U3_8OJP!J"3T"*U.4MWHY;R)5*DUKV5#]HW*B$2
M)'^QL(#J+T7<P0T&IB_<84O;2Z*'7BUP("],51;VRA3-J)=+P_W0_RBJ;;UN
MVW'#L1" 7FW+HDW]8D)@$04$;6+RKCE853BT2'AI]W $#Q9$5;LR&*.-4TV[
M3K<M3HJ =[:2)MRG2 81H B%8;]R&J=@I7Z@]*,R-!90W8_2FBW';*>.W;>@
M_LB42>,H)7!ZJV_88(O]QZQ ]R&+#45!:Q&GMPXR3)PR=/(".*?:X%060^1&
M BJM'W3H-P^CIVW0%"J]'TL63(?2A=/;,F2)EK&-#F,,F[06<Y?M-GSS@R>!
MB!HY+(ZM[X\(2IIC;NXQX+* FM.G)^C#E!G:BPO30*ESN#$#S  SH#<#M""9
MK61W'#YY56_7#OV9]90D\9VW?!]=TX[X173=2GDPLE=UOV[Q-0T9H-..:0MU
M4$6,U +FSP(JI?49.&XE>@]7I[Y(X=RI,$5)RQ@^;$@MH'MDDWXOTQ7NA-,7
M;GID1\W!U<OF "W"R=180)4I6G)@7;;^$"HU'J5*VG!G9TS?R>@$>-&\J9T=
M8II^5*>)TL->O_G0\#G1+O5IP^JC?/',AF,1!0"E73RFI'=3LW5H7,*6$4)-
MF[+9HC3^S;K.,+R,"94UJ%D^EVSTZ8*73@Q33509&@NH[D6)LO6DRM\>EZ[=
M<\^ 1J.F*1L_*Y0PW_\AXCMCT2Z&?_?A_T$:O7&=-%N__6301D51V\:Y'=%9
MJ5^N5?G&D"&"HGC^M*A4,@MR9TDFQ<$V^HS>>^0R6PDBT4\0VWM?4;D..H'.
MS3T&7!90<Y?M!:J+8(;V^/1DT"\N-V: &6 &]&9@R=J#ML5)O?TZ\D?%UJ_N
M'XE0(8(YZB;M/4I'E;%8%]WKN/U,&"T0TX[/V#$B_7R9G^O P-)U!U&QT2@=
M/+GNXKN 2O5%J#:H&G5;:1&\8Q-O=&Y64NB:=I3"G-(LB]+R9DN.U3/:B@+'
M*1PLH#I%$W=RD@&J;U2X2G]=ZZ!1G2,Z!48[T*W:=NP[BX)*FE@]3_S:XYK2
MO&]0%L\RIDY@KXMEKF_9?1I%J@Y0=;YTNN+BKF&(^4=$5>W*:.S:OP^4[T.C
M#4V1U[]C!5N) QGYTP,SO?_I]T#TQ@*J>Q$2(4N3;^1_1 UO^QM)62G,V.C_
M?0'E=+>1C3)C7=@YC$^C&10$VMR=)$=+7=+BNC/%$,&#:%+^BDZ6UZZ0&^6]
M,X/>@S*V,Q=OH5V?N=B\2ZR4Y\YRN6YV>^3*_+>SW;G?3PRX+*#F\.F! T<O
M_V1"WJ=WCXT7\D2&O(PR<F: &7"& =JQE*I >UR\>M>9[KKU:5 U'X9UKZJ;
M/R,<T8D:$J^-;+4KYL;HWC6,A&!)W[0HG2QW&URY<5^X^9. VJQV(3173F+0
M%RI/&WWIF3RXGA2U/*D.4-R,3?#HR4M/IZW*^.2)8^'0VKZJV-++" NH>C%M
M?C_T]S%;R6ZZU[T;T;,:ZE7.:WZ"_9EA\VXS,'[69G]ZZ7,[<L0PV+>RI^5%
MOM)UAH+26ZK9<F9*BO5S.JAI4FI;[S]\0IM>LS%QSA9#YD&;S;JV*&V(;QF<
MTF)QNL(==<U(X XO+*"ZSAJE9TZ2LQ7NWG_J^F -1]#FS\[-2FGHP7C36M35
M=G56[1H61X_695P=QOU58J#+P(48-'Z52M;$-4.;NJFF:8LZA6TI>L5%ZAHR
MJ@W;LL=,83.<V9M-T@0Q;&L=M'F5FVL,N"R@9BO5'8>.7W'-BZ"]K^\?A6A1
MP@F*CF$Q \R 61F@XO$U6HASXNH[SX?7]46R1+&^OS3E(Z5,SNK=S="YT<D.
MVO')_W_T#\/0B6O0L?]\_1W[XY$^P*J5"B:ZLFM[R:26(%%6ED;UB6D'O B-
M^+NZ;Z0(4)S&P *JTU1Q1P<,O'S]SB:>4JT?/1L)IR2@<@->O7EG2Z5X\\YC
M(>A(DSPNMB[J"OK<8L5&M3KC96ZJVO_G[QP.[U$-]:OPAH'O?'Q_I.]'C3I.
MT>34RW<??CTVKE$ @[M4]NL67_N/@6K-QF+!JGU"\\$"JNOA&3MCHR( S')]
MH(8CK')"?^..DRA>8Y"&3/IO.FSH$+BT9SC70O6?*DUZW+CU"(F54Z@B9![1
M9(**T6+Y4BL;E'Q &Y3-V.B[$VT $SD=LU^\C^M7"S7*Y?3K%E]SP("E!=1S
M2F'DN+&C.*"';S$#S  SH"X#] $I3<$..'OIMKJ&/;3V/86HAV:D&$YUQDZ>
M^]=0K+SCTQCZ:8?U7UF:";^+WEUV*"W.LLFM$#U:>'=-&#)N]>:C\*D[S!#?
MOIU2"O-'IR?YOBST:Q90A0Z/%.#HLTFY!B- NZGU;"30;5_2#69-T^<.ER+]
M/23\5!N2:D1:L8V<NAYM>\]1?>IGE36(>+P&X2>O]/F\;/WANM8#KN*3#9,&
MUO43#U_\Q@!];Z7OKR(O]+. ZMJ[E3+ 4 K16W>?N#90X]YYLB;#FIGM-/9B
MO'GZ74J8K06,WC UH%-%-*M5R'A"+(H@;_D^V'WPO.EFGR));%MFNRSI$IEN
M;GY-B$I%U6\WV?":[GYA\^M:K.@109]%^?N77^S8O^:R@&JF%+Y6.&UE/_1\
MAQE@!HQ@8/WV$_"N.=@(UPY]6NG#\_#):]&^[SR'?&A],V+XT+93;E8]U:$U
MOX[L9R_= P>/F:,4P<_SS)\C!>:.:2)E#>.'CU\@5KI&/T_'D.?I4\5'3R65
M%:57E*FQ@"I3M,3$2BG$*)68GBUDB* XL+HWXO\934^W4O@JH7Q.W*!\7A2E
M31_> .6+9Q8%CFXXLI3HBB.GKJGJC[*/4!8L;O89>/+T%<HU'*%*/7C[7G[<
M\2Z0%O/'-?MQ@9_YR8!H?Y=\@V0!U3<CCE_/7;8'-5N-=]S)@+N3!]5%Y=+9
M#/"LO\NN@Q9BX#AC4[C^&2LRSFX; CKYRTU_!D8I&[7::+!12_^9?/,8+DP(
M=&]5!G64DE562Q%[3MEH1/\GZ7NY#(TVCM$&,F[.,^"R@)J[;"_L/7S1>0\"
M]]RQN!LRI(XO,$*&Q@PP V9CH$C5 =BR^[10TZ*Z!)=V#[-,G:M;=Q\C0=86
MAN^BMNJ"I-%O_E[#EZ+/R&5&PU#5/RTTC.]?"X&\O%2UJZ>Q/U+5Q]/GK_5T
M^7]??R>,::L!5#1OZO]?D^D)"Z@R14L\K#OWGT.A*OU53U/JWTPY?91]AF@1
M)JU2<U"MU.[V/3EW)W3(8#BXIH^E,C==O_G0EEK/.8:<[U4X=RHLG=S2^0$6
M[4FGXQIWFH89BW9HSD"NS']CW>SVFON1W<&Z;<=1LM808:?! JIKH<E<O"N.
MGE9W@XAK"'[O'21P(-P\/ :46M8*C4[<4V8LH]O*:6U &W&YZ<\ G>Y/7< <
M_W_*%LMH2X<?)5)8_8D4Q..=>T^1KT(?7+EQ7Q!$]F%0YC+:R,K->09<%E +
M5.J''?O..N]!X)ZKIK=%ONS)!4;(T)@!9L!,#%R^?@_)\[0U7+CSS2FET-NS
MHJ?ORZ9^+<*71EZP,>8M)D+-&35GWKQV(?3K4 &T$4+F]D_^=M"[]B*E4.S2
MHC3*%<LD]<YK%E!E?N<;B_W1DY<VH>[>@V>Z F$1R7^ZZ[:=A)F+=_K?4:<>
M&5,GP-:%7:3^6^D*55JE[VU1I[#M?[8K6*S<=\#8E>@^9+&FWYW2IHB'W<M[
M6)EFI^9.&SJH#(;>_R^< J=T8@'56:: 0\>O(%NI[LX/T*EGWFS)L7I&6YV\
MB>$F4?86H%J81K;2A=-CSN@F1D*PK&]*Y1SMG_IX_O*-M!Q$C1P68_K4A*P;
MD=4FGGZ?LWAW!7W'$KWM6M8=Z5+^)3I,8?"Y+*!2H6M:?#1#FSVJ,7R*9###
M5'@.S  S( $#G0;,QY ):X1#VKE9271N5DHX7%H"ZCEL"?J.6JZE"W]M4ZJ<
MR[M'2%>OTM^)"=Z!ZJ#&S=14<)3.P>O>R@?M&Y5PKK/@O3(6ZXSC9V[H@O*/
MJ.'1L;$WJI?+88K:'RR@ZO*V,9T36K3Q5DX3Z9TJEDZ6'-_8'_1[R,T^ W0"
M,EGN-OCT^;/]3CK?Z=N^/%K6+:*S5V/<:;5I?'"7RFA<HX QDY+4ZYRENU%/
MJ2VFU>]"@KC1<&K+($G9T1=VZUZS,7K:!GV=.NF-!50GB5*Z->@P!=,6;'=^
M@$X]AW:K@H;5\NOD30PWS;K.P(39FPT%$RQH8/Q[: S"A IN* ZK.I<YRV<)
M)07^N+ZU$"%\**N&S\]Y;]IY"L6J#_3SGD@7:U7(91._1<(D,A:7!=2R]8=C
MY<8C(L_):6RT2X+>,-R8 6: &=":@2]?OMIV[9)X(UK;OK@KZ&2!E=JN ^=M
MZ36,GC,OI!D3@7!):N+=^X_&.%?)Z\#.E="T9D&5K!EO1H]3X?3EKG6]HFA0
M-1^"!PMB_*150L "JDI$6LP,+8+38KC>;73O&JBMU$;BYC\#-5J,P[P5>_WO
MJ%,/6F0]LKX?_HH352>/QKAY_>:]<B*D'BB-K-IMVM#ZJ."=16VSIK>W=NLQ
M5&PT2I//;G1ZYL:!T:;G4(T)BO+]R:^YL(#J%RN_7WO[[@/BI&^,%Z_>_G[3
MX"LG-P]$PGA_&(Q"7_?+-QQ&^08C]'7JAS?^W^0'*3I=JM5Z FBCD$R-TFW3
M6D3]*GEE@JTKUD:=IF+*O&VZ^G35&6UJO7%P-.CS/3?_&7!90*W>?!SFKQ3G
MBYS_4[3?HU?;LFA3OYC]#GR'&6 &F &5&-BNI#XOJ*1 %ZV%#!$4]T],D+IV
MHCN<DG@6.7D=31;'7,&3+4-B;)IG?.T35S";H6^"K,UQ\\YC::=BQAW:&8IV
MQHFSVIQ #14B&)K6*HCF2NI$,^ZN9@%5VE]EPX!3C<U,Q;MH(D8XFE2ZE/&P
M<VEWZ5...YJCFO>H/AUM+A&I6:'\ )W*+E%SL":T4YI$2I?(S74&J(Q4J3I#
M00*WFHTV5#T].T5-DZ:U1:> HZ:LK\3@G7!S9 '5N9 L67L0E1J/<JZSCKVB
M10F'Z_O%PZ4U!0\?OT"L=(VT=N.O?6_E).'\<<W\[<<=U&>@0[]Y&#9IK?J&
M-;)(OZL+E?=*^E3Q-?)@#K/T625=X8ZX^N\#H2?$F5F=#X_+ FK#CE,Q=;[8
M*KJST^<:),XRQ?V8 6; 4P::=)F&27.V>FI&]?$Y,B7%ACD=5+<K@T%:/#YV
M^KJA4 -Y>>'VT;&@W5_<]&/ B'J;:LW.K*>6D^=I@TO7[JE%D\U.T""!4*]R
M7K1M6!R1(H16U;9(QEA %2D:XF.A!?#L)7N Q#D]&]5IWKFT&]?:<9'T;"6[
MX=")JRZ.TK:[V1=;N@Q<B$'C5VE"HMFYTX2TGXSN/7P1Q:L/PBN5!;Q7EZ9;
M;C/I3[2Z]#1OI?[8O>^,2V/TZ,P"JG,L5VXR&HO7''"NLXZ]2A5*C[ECFNCH
M41Q7";.U 'V6-[*%#AD,=XZ--T5I$R-Y=,=W[Q%+T7O$,G>&ZCXF6:)86#&M
M-6)$BZ"[;QD=4M:&_!7[:EK'W5->BN5+C4436GAJQA+C7190V_69BQ%3UIF"
MG"H^V3!I8%U3S(4GP0PP ^(R0'7&XF5N!A'3]](I?#J-;\56M^TDS%R\T_"I
M+YK0',7RI3$<AY4 I,S7#A>NW)%NRKW;ED/K^D6EP^T,8-I]3;NPU6BT,8$^
MXW5JZHV8?T14PZ30-EA %3H\PH$;,'8EN@U>I#NN"B4R8]JP!KK[E=WAY+E;
MT;CS-*&F$2MZ1%O-2+.F_,I3KC?V'+J@">?3AS= ^>*9-;%M%:.[#YY'\1J#
M\.;M!]6F?.?(.*[AYB2;K?HLP)@IJYWLK5\W%E#]Y_K#QT^(D;H!7KX6[P2Q
ME6IL^XY4F7K#L&K34=^7=7^]=6$79$Z;4'>_5G?8:_A2]!DIOH!*);](/.6-
M_ZZ]8T6M.?U]%K3A_);R&8@V47!SS(#+ BK]8M,ON!E:P9PIL7QJ:S-,A>?
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M3F'TZU#!>J3]-V.1!%3>Y:?OVU!$ =6[0%K,'MW84N(I1;UPE?[8NN?,_]\
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M"ZA"A8/!N," 2 *J3Y$,F#U*WTP,+E!ERJXLH)HRK XG9<2&/8> ?KIY?.,
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MY3K(]KEQ6T!MVWL.1DY=;]^R1'<HQ=23LY,1R,M+(M0,E1E@!I@!9L 3!EA
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MKU]]?ZT\OG[SWO;ZM7*?KM-K6W^ZKO2E+R7T^(JNDRWE-:5;$[FQ@*IO=%A
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MJ/I&G054??EF;]HRP *JMOR*:#U;J>XX=/R*4- 6CF^.XOG3"(6)P3 #>C!
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M4PN%B<$P WHR,&'V9K3J,=LTF;CTY,Z1+R^O@"A;+!/:-RJ.1']%=]25[^G
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M<FA0-1\"!.#3J&JQS *J6DS*:X?JF>[8?TY9D]B%%>L/X]4;%DWEC>:OR%E
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M]Q8+J'+%GE+VEFLX G1"7;26)$$,S%764>G1JHT%5*M&_L>\64#]P845G[&
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M#JWI@^C1PJMBSS\C"Y3Z0C5;CA?NBTK,/R)@U?2VEJXM8B]V+*#:8\;\UUE
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M@5<RZ"F\ CYFNB;$(7-DDYU+>U"F-/%E4\LT^L" :IJA4EU1&%!51XH*#22
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M!\J5.8GJ=3M:X;B9FQ1O9T?+ZU6.KQ?/SDVCD"&"Z=6D)=N! =62P^I0IV!
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M9Y4SRYA^R&A 94>?%Q=F& ,$K?XD<.CX5<6I].<&B3_PZKU]J_H01]J!F(/
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M4;-N,VG^\KV^=HG#$7-88ADEN<@%>.7&0VE42YL\-NU;U4<:?:"(N0A<OOZ
M4N3K(*72FX3A*V?F)%+JYHY2]QX^HU(BK-Z9BW?\K(8GUI=-;2-=;NN^HY8K
MCG9^*B[AC@CA0M.JF>TI?<JX$FIG/978R;A=WWG$]TON2)3?P]&V1=VDGU2?
MLW0W->@PU9VN.G5LV2(9:.;(QL1.IQ#M"+"3)$>;T4*2Q(].QS<-TJ)JZ>MD
M ^K8J6MIW-354NE:LWQ.FCRXGE0ZJ:',LO6'J6JSL6I4I6D=G%:(TPM!'"/
MUZ=Q,S=1CV%+B)^I99-9HQI3I1)99%/+5WW8R8O_PU=M.NKK_H&=*RMSX+[N
ME&!CGY'+:,#8E1)H\I\*%W>-((YF"=&> $=Q6['QB/8-.=@".SZ_O#C3P=+V
M*F9; RH/\[G+=ZE8S2'TX-%S6XUZK!B1%.^\<D4SVJK?5NTL3W),G+.%1DQ=
M1\^>OS&LF]&C1!"36^TLLT* \SE&3]O$,)Z.-LPYPDYM'8(0&PX XS"7G/]M
MR^XS#I0VIHA9)F0X1'BEQF.(5S/Y)YSOB_-^R29L;&*CDRS"J\AY-3D$!%PA
M(+,!M4V#HC2@D[56A!P[<T.)9./?\T.,J!&(PSLF%I/LL@FORLI:LH>_QE_9
M=&9]>$7$O+'-J'#N5#*J9QF=CIRZ1K5;3R+^GW='_H@<5DE+D#!N-'>JT>78
MU9N/406QFEQ/R9,UJ7 Z;44<IAJB'8%0\6H0YZE66S@<\\A>VAAGU=95[?K8
M@-IK\'Q:L$RNL++\W[!B>ENUNVMX?3+?XWF%\UNH$'1^YS!I0[5[U=7HSSRF
M')IY_]'+1JOB9_N<>H(=H&27TQ=N*VF$KMUZY*>JO$)ZVM &Q L/9!09'1LO
M[1Y);#> :$^ TV1PQ!=9A!?;O;@P0Q9UI-+#U@94'@G.UU:\UA"Z>/6^5 .C
MAS(94L>CP5TJ4^:T"?1H#FVH3.#-NP\T>>XV&BD,IQRVUTA)G>PO6BY6643]
M([R1:JC>=H+LK8F-;K(+YSA>+59F0'PGP&%<QL_>3'U&+"/^W<@N/)8RYZWF
M&[Q&':?1JS?O T3)JX;.[QQ!X<*$"K"LG@42YFA-',99%DF>*"8=63] %G6@
MA\D(R!K"ES%R[D,.ZV856;SF(#7L.-7?U0+L"+-F=@=BQS)9A2><LI7J26Q,
M-9-P;NU!8B6!C(XY9N+HFZY\+O0?O8*&3UY'7[ZZEP*$C:>;YG>A1/'D-YXR
MB[V'+U*^2OU]PZ+I-L[MNVI&>V)>$&T(\ I4+=)U<'2!HGE3:Z.TY+6R ;5)
MN_&T;?<IJ31-F206'5K;3RJ=U%"&'0"BI&KHT'.7&NVY4T?EDEF4U?7NU&'E
M8_E_=MBDM31X_"IOJ6]D[;/LJ:)F+]E%K7K.\?>>W),MWY.?VS%,RDB,W88L
M4LX+3UUE>#\M%F@DB!-5!E4LKT.Y!B-I[=;CTO0S4*#_T;NK<Z311R9%;&]
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M>$>$Z#U,*S8>D2[NN<].MJY?A/IUJ$@<8LI.PH8DOJGY]NV;Z;K-^=BF#FE
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M1?*DEEE%776# =4-W.\_?*). Q9(F_39C:X9=B@_H/ *'#:D1H\:0?G396.
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M;CVB&BW&6^IYB>\GN[<N0^T;%;>=TS$,J(Z>^6Z6XY"?8V=NI*$3UA"'VH"
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M [M2G2;'L",8C_].D5J _SO/7+P-H[D*I#G=(*_D9R-ZM@P)315*'P94%4X
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MFCH%4,7",*"J"%/2JCBD/L])K!0&U<\BK*<9A!V)>3Z"5SWF%-&O^+\5\IT
M.^SS?7[7P8O$"C#M(F2QX;ICTY+4O$XA\,?)!P(@8#D",*!:;D@=[Q"'"=HE
M\J_L%-[=G(OEV8NWCA^,DC\)<$ZB;!D2*J&U.$1O$I$8'<OZ?^+!!Q<(\(3A
MXC4'E;S&G-^8;WIE$8[;GREM?!$F*P7E%PX"J9+&POD>P.!PB+9N0Q;3K,4[
M5350<$BB!M7R*OF>X'T?P"!@-PB @+\$SEZZ0WU'+1?YDHZI>IWRMU$_=G)(
M1@Y%SJN+2A9,;^D\57X@P&9?"' N'5Y!L7GW:=JR^PQ=NG;?EU+R;^*4!JF2
M_"4BU"11SG-^=K!BOD;Y1\*<&MY]\%2),,51IDZ=OZE\OG/_J3D[XX_6G.HF
MF_AM\.^#PU<G31 #(:S]X:7G+AA0]:1M;%N\X&+AZOVT>/5!8D=OF80-I'Q]
M4.8DA%-%LH0Q95)/2ET>/7Y)'?O_K8RIF@JR@TN3&@7$*[^2CD?-NE$7"(
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M,W__(#ZSMWAPL9(AF$@0SX9.?O%W?O]O6S#%\SNXEWT<CQ\" B   B   B
M B   B   B   B   B"@#@$84-7AB%I   1   1   3,0P &5/.,%30% 1
M 1   1   1   1   1   1   1   =T)P("J.W(T" (@  (@  (@8# !&% -
M'@ T#P(@  (@  (@  (@  (@  (@  (@  (@  (R$X !5>;1@6X@  (@  (@
M  ):$( !50NJJ!,$0  $0  $0  $0  $0  $0  $0  $0  $+$( !E2+#"2Z
M 0(@  (@  (@X# !&% =1H6"(  "(  "(  "(  "(  "(  "(  "(  "(& _
M C"@VF_,T6,0  $0  $0L#L!&%#M?@:@_R   B   B   B   B   B   B
M B   B#@#P$84/V!@UT@  (@  (@  *6)  #JB6'%9T" 1   1   1   1
M 1   1   1   1   74(P("J#D?4 @(@  (@  (@8!X",*":9ZR@*0B   B
M  B   B   B   B   B   B   CH3@ &5-V1HT$0  $0  $0  &#"<" :O
MH'D0  $0  $0  $0  $0  $0  $0  $0  $0D)D #*@RCPYT P$0  $0  $0
MT(( #*A:4$6=(  "(  "(  "(  "(  "(  "(  "(  "(& 1 C"@6F0@T0T0
M  $0  $0  &'"<" ZC J% 0!$  !$  !$  !$  !$  !$  !$  !$  !^Q&
M =5^8XX>@P (@  (@(#="<" :O<S /T' 1   1   1   1   1   1   1
M 1   7\(P(#J#QSL @$0  $0  $0L"0!&% M.:SH% B   B   B   B   B
M  B   B   B   BH0P &5'4XHA80  $0  $0  'S$( !U3QC!4U!  1   1
M  1   1   1   1   1   1 0'<",*#JCAP-@@ (@  (@  (&$P !E2#!P#-
M@P (@  (@  (@  (@  (@  (@  (@  (@(#,!&! E7ETH!L(@  (@  (@( 6
M!&! U8(JZ@0!$  !$  !$  !$  !$  !$  !$  !$  !BQ"  =4B XEN@  (
M@  (@  (.$P !E2'4:$@"(  "(  "(  "(  "(  "(  "(  "(  "-B/  RH
M]AMS]!@$0  $0  $[$X !E2[GP'H/PB   B   B   B   B   B   B   B
M  CX0P &5'_@8!<(@  (@  (@( E"<" :LEA1:=   1   1   1   1   1
M  1   1   1 0!T",*"JPQ&U@  (@  (@  (F(< #*CF&2MH"@(@  (@  (@
M  (@  (@  (@  (@  (@  *Z$X !57?D:! $0  $0  $0,!@ C"@&CP :!X$
M0  $0  $0  $0  $0  $0  $0  $0  $9"8  ZK,HP/=0  $0  $0  $M"
M ZH65%$G"(  "(  "(  "(  "(  "(  "(  "(  "%B$  RH%AE(= ,$0  $
M0  $0,!A C"@.HP*!4$ !$  !$  !$  !$  !$  !$  !$  !$# ?@1@0+7?
MF*/'(  "(  "(&!W C"@VOT,0/]!  1   1   1   1   1   1   1   1
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M$$A6LJ.W6LZN&NSM.[Z   B   B   B @%D(P(!JEI&"GB   B   B   B
M B   B   B   B   B @,0$84"4>'*@& B   B   B#@% $84)W"A<(@  (@
M  (@  (@  (@  (@  (@  (@  (@  *^$8 !U3<JV 8"(  "(  "(&!& C"@
MFG'4H#,(@  (@  (@  (@  (@  (@  (@  (@  (2$;@[)4[WC1*%C^FM^_X
M @(@  (@  (@  )F(0 #JEE&"GJ"  B   B   B   B   B   B   B   B
M  B   B   B   B   AH3@ &5,T1HP$0  $0  $0  $0  $0  $0  $0  $0
M  $0  $0  $0  $0  $0  &S$( !U2PC!3U!  1   1   1   1   1   1
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M?X_3WR\==.=[$7M_PA2KCVL/R94WS%2)[\F@FS_CAS*IZ >NFUB_\37C/K/
M=7WG%9ME?_6OI/_YV<ZK4#)T!!!00Q<2#(( !"   0A   (0@  $(  !"$
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ME4^.-5YR&!&GA(A76YG'[21.IN8:C-,,62DB@(":(O!T"P$(0  "$(  !"
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M]FA+APTY4UY>\T1T4N#'^K$CLG;1'3)JQ%6!VTJ'X2: @!KN^& =!"   0A
M  (0@  $(  !"$   A#HM 004.U#CX!JSR8(<2&Z=S>3]?EY?8QOXRV,;B:I
M8^VU,G_&2$/ '7VBS]QA4^3 ![6*_H])8\WSBO+.B@89-RVOB <(J!$2(GY_
M\UA_735(_;LKI&O7KJU&>G3D9KSXL<H\XH[?UXK;;:Y%_(M!Q'<GO_JQ(^+7
MBR%.[*5,> D@H(8W-E@& 0A   (0@  $(  !"$   A"   0Z-8&P35J;P?![
MXMIIP!%0[4D%'2,W8H/7W]O3VO#I[D62V;OW"8ANMNIT(B3:1\@Z)^BX:?LS
MK7;BM[9=OX5(:]KM4\-FMUX$\T^\"]NSR.]8%=S\F/+;R"WC*?K%C/8C++@4
M_=@Q;:LW!/C_\$6 #\YS>O*:  *JUT1I#P(0@  $(  !"$   A"   0@  $(
M0, 3 F&;M#:=\GOBVBDX!%1[4D''R,UVL%ZO3M-\TS.R?6^$H)MM?.\<?9DL
MGNO\>ZN1ON+]!ATW_<I;$2???PW:CWA,-7EALULO@B&@VL5;(](W-S=+]XMN
MERYVC=FF-\CQ?<LE(R/#MD10&6[NR:9MA05?,;ZK^FA09M)/&A! 0$V#(&$B
M!"   0A   (0@  $(  !"$   A#HC 004.VCCH!JSR9H(6CE^BTR=LIB>X,L
M<KP44)N;OS $C]L<"QY6J\3T8N)Q:=B_6KITT<LL%CA.) 4=-S??>&0%:FOT
M-*)<:RWG1PBH]JS\O%;<BH]C"O.D<L%#]D8'F./FI9"(>7>.'FR\'')?Y)3?
M3DX  ;63#P#<AP $(  !"$   A"   0@  $(0  "826 @&H?&014>S9^B@M6
MO3Y2MD9FEV^PRK)-VU7UL%R:-\ V7Y.Q=?O;,GS,;,=5HK?OC51RLXVOESZ8
M=@0=-S?;E"*@1D8,WT!M)6%]Y.5+$FU[\/-:T3];6JQ[ZZ59,B#W@K:FINS<
MS0L2$6/S\_K):^M_)3UZ=(\D\=M)"2"@=M+ XS8$(  !"$   A"   0@  $(
M0  "$ @[ 014^PCI)[GUVUOZ.4EO[UGR.4':75_?**=>4J0TNED^W;WDY#=(
ME97;%=<(@6VW[XTTYF;%5F%!CK'=I7/A-M*7W6^0<3-M<".P(*"V1H\5J*TL
MK([254#5W$]:_?9^17IKV^Z.W/D1VU?IM._)SR>.\72E?6P/G(6=  )JV".$
M?1"   0@  $(0  "$(  !"   0A H),2Z @":GY>INRL*O<\@OH5@_X+J/EY
M?0Q?%WKNJ[;!((6X']^S0%;_X365B5F9S5*[JU)5QZYP8V.3]+QXO%UVNW2K
M[7LCA?3;^.K'5*0OJ]\@X^;FWB+29'SC\;<)O_&H]:,S7C=6\6^;QA:^;8FT
MGFO'F$;L=O-B06%!?^-EBL=:#0S!T:;J75)85.:!)<TR?\9-,F'<R(37O@>=
MT43("""@ABP@F ,!"$   A"   0@  $(0  "$(  !"#00L"-R.'GJA_3*NW$
M=59F-UGQ]#V>AK3WJ;UD3OD?I*IZMZ)=O=BE]54S2:\P7%TT*+OUJX!;7'FV
M]"8INN5ZM5]6%=9OW"8W3GS&*LLRS6K[WDA!O2@O\LJJ^V3HY8,C323U&U3<
M3".UW%H<.R:--<\G]#%(/Q(:HR@0-KL14.V#YU>L#A\Y*GT'3K#OV"8GWHL9
M-E5\3W;S_X=$1OUD]!52]M =QNX!7TI4E/P.0@ !M8,$$C<@  $(0  "$(
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MM&/,::STS%MLK-VY4+).ZV-O< ISW&Q)[-3<K,P,V?2[!^3K R]Q6H5R:48
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MTRN\;]BBQ5=639.AEP^RR"$IW0@@H*9;Q+ 7 A"   0@  $(0  "$(  !"
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MPJ]!CN];+AD9&4YQAK:<&><-FUZ3'TY<Z/@E%:?.;%OW"_GZP*\Y+4ZYD!!
M0 U)(# # A"   0@  $(0  "$(  !"   0A ()9 V":M3>NT$]=NMP&-)='^
M3+]22"\N:'UU.DG?WAMO4[1VBS3)3T;'?K-T[_Z/9/..=Y,RS(_83WUTN<Q_
M;J-#NYKE\)[_+;UZ]7)8/K;8RO5;C&\$+HY-3'!64CS<$!]_FJ"4=;8^;M;M
MN$]MD/W5\XSO[F:[;\*HJ?4C7:\;O^U&0+4?AGZ-L:W;WY;A8V;;=VR3L[]Z
MCG'=G&>3FY[)>_:^)R-_\I0<^*#6$P=8A>H)QL ;04 -'#D=0@ "$(  !"
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MWS7JUK1LLS)%=KSX*\OMB<UMBT_M=8KT[-E#>O4\Q3>QU,I)K1_I*J!Z]6*
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M?*?F _GJ=QY0-:5]J435.(5](8" Z@M6&H4 !"   0A   (0@  $(  !"$
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MHX:@>V;2MI@-N/TNM9^KI#UQC$;:$4! ;8>$! A   (0@  $(  !"$   A"
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M,LG+/5=.Z]-;NG7K>J+()Y\>EO]Z?:\AZ%;+YAWO1%=3'CM?B:]LF.(^$T!
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ME6G:R3^W]^*3#7AX\,JJJ3+T\LL\;)&F@B: @!HT<?J#  0@  $(0  "$(
M!"   0A   (0<$0@;)/6IM&IFKAN"PP!M2V1UO-4Q4C;;XO%[;\/JE_-VB#U
M[ZZ0KEV[MD+P\<CM-KZETZZ5^XO'V5JFY>>5*&1KD,L,K1\NNW%4+5D!U>QD
MS]X#,NBZ$D?]^5^H23[<]HR<<7H__[N*ZB%LSR+M&//R6@G/"L_CQK;EJRVW
M+<\=-D4.?% ;%<'@#ZLJ)LDU!=\(OF-Z])0  JJG.&D, A"   0@  $(0  "
M$(  !"   0A P"L"89NT-OU*Y<1U--?.)J!J!(!4Q>CUW35RQ0V/1(?)T?&S
MI3<9WP>]_F19[>3_L"%GR,MKYIVL'\2!EK%I4Z(8:MM,U%X0'*SZT/IAU897
M:5XQ,E?U91DKK+MX99B+=O+S^LJ.WS\5V(L"T2:&[5FD'6->C8,(D_KZ!KGD
MV_>G4*2LET]W+Y7,WKTC)L7\'JH[8JSBGQB3%MQ)O2'R+S)$_B\'UR4]^48
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M(-R/!?-Z+"Y9YNMX'5,X4!;/G6B[(M;:)U+3@0 ":CI$"1LA  $(0  "$(
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M@  $(  !"$# 0P((J!["I"D(0  "$(  !"   0A   (0@  $(  !"$   A"
M  0@  $(0""]"2"@IG?\L!X"$(  !"   0A   (0@  $(  !"$   A"   0@
M  $(0  "$/"0  *JAS!I"@(0@  $(  !"$   A"   0@  $(0  "$(  !"
M 0A   (02&\""*CI'3^LAP $(  !"$   A"   0@  $(0  "$(  !"   0A
M  (0@  $/"2 @.HA3)J"  0@  $(0  "$(  !"   0A   (0@  $(  !"$
M A"   32FP ":GK'#^LA  $(0  "$(  !"   0A   (0@  $(  !"$   A"
M  0@  $/"2"@>@B3IB   0A   (0@  $(  !"$   A"   0@  $(0  "$(
M!"  @?0F@(":WO'#>@A   (0@  $(  !"$   A"   0@  $(0  "$(  !"
< 0A P$,"_Q^NQ#=PK_F*EP    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm139898695177408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page Document<br></strong></div></th>
<th class="th"><div>May 22, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 22,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CARTESIAN THERAPEUTICS,&#160;INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37798<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-1622110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">704 Quince Orchard Road,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Gaithersburg,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">20878<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">923-1400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock (Par Value $0.0001)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RNAC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001453687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M"2B>^"[X-CLY)^95EE*^F,$D'%B.(>(1#[218'!XY2,>148)./X]B%KE;YK
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M4$L! A0#%     @ %SFV6(@HJ5WO    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ %SFV6)E<G",0!@  G"<
M !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    "  7.;98\6M:AUL$  "7$   &               @($."   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ %SFV6)^@&_"Q @  X@P
M  T              ( !GPP  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  7
M.;98EXJ[',     3 @  "P              @ %[#P  7W)E;',O+G)E;'-0
M2P$"% ,4    "  7.;98VU\'[3D!   P @  #P              @ %D$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ %SFV6"0>FZ*M    ^ $  !H
M             ( !RA$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ %SFV6&60>9(9 0  SP,  !,              ( !KQ(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ^1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="rnac-20240522.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cartesiantherapeutics.com/role/CoverPageDocument</Role>
      <ShortName>Cover Page Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="rnac-20240522.htm">rnac-20240522.htm</File>
    <File>rnac-20240522.xsd</File>
    <File>rnac-20240522_lab.xml</File>
    <File>rnac-20240522_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "rnac-20240522.htm": {
   "nsprefix": "rnac",
   "nsuri": "http://www.cartesiantherapeutics.com/20240522",
   "dts": {
    "inline": {
     "local": [
      "rnac-20240522.htm"
     ]
    },
    "schema": {
     "local": [
      "rnac-20240522.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "rnac-20240522_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rnac-20240522_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.cartesiantherapeutics.com/role/CoverPageDocument",
     "longName": "0000001 - Document - Cover Page Document",
     "shortName": "Cover Page Document",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20240522.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rnac-20240522.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.cartesiantherapeutics.com/role/CoverPageDocument"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001453687-24-000084-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001453687-24-000084-xbrl.zip
M4$L#!!0    ( !<YMEA'ONL0N!   "=\   1    <FYA8RTR,#(T,#4R,BYH
M=&WM/6MWXCBRW^=7Z#)[MY-S8F,;\TS"'H8DO9SID%Q(WYFS7_;(M@!-&YN1
M[ 3VUV^5;!,@0""3-)#.](>)7Z6J4KTE%6?_& ]]<L^$Y&%P_LG4C4^$!6[H
M\:!__JG1;;9:G_Y1_^GL?S3M]U\Z7\A%Z,9#%D2D*1B-F$<>>#0@T8"1WT+Q
MC=]3<NO3J!>*H:8EGS7#T43P_B BEF'9V6O94U&KFJS2<TH5S3'=DF:[#M.J
MY:*C>;9;9>626:K:I9-^C9H]YEE.22NYCJ/9%;NJ52NTI-%RB17,<M6UO?*)
M5W,*+O/*!<.@-K/M@E.IF*9G%2K4IH;E6;8:=Q !S4!W(&M\'&F2N>>Y012-
M:OG\P\.##M=Z/[S/\\#G 4.R\Y&@@42J: 1\REN&6=2,BE8P<X]PYF",'>'K
MH>BO!6(9FF%III4!\1B? E$ ,DS@ ;Y>2%^<&^FAH,8QJ]5J?HR49=#&,/"W
MU:_BT^FKDB][T3(,,__[]9>N.V!#JO% 1C1P6?;5$_A3HN'#0AX?.U2R1Q:M
M>MDLS+!IBA,\YVO SV%3\RG(:XX%VM=NKGXV8-2KGPU91 E^K[$_8WY_GFN&
M002RJ]U-1O"9FUR=YR(VCO**<_GZ3S_]=!;QR&=U$5!70Y$UBI9UED]NGN43
MT$[H3>IG'K\G,IKX[#SG<3GRZ:06A $#!/BXAB\RD?S)/8\%ZD]XW@8%$MQ-
MQA]''=8[S[D:2%) APB)\=IE ,--FH"=H'XK\-CX5S;)$>Z=YWJ:9>;J!LR,
M72R4*N6S_!S4+09I@!Y[J,M7/NU/@5NY>H_ZDCV!FY\G1+ >$V IF%S"?YSZ
MFE12 R,3)6NU"+A^GI-\./)QTM2]@4#$YEBMCZ4'$Z'&>QPD'5.&L5!72CIJ
M*74*=Z0NN\\4_[(K[N%UCS-!%$YLJ;8W6[_.\W7QXWIV:Q[Z"-@3>MD5R*2(
M+L RUI$>S2AJ*#R+SZ9H>BM>S9YDU]D@^3FZ,R9-N9*?D;L\2&<BHL@=_IQA
M_#=R[_&;5*R'/- &#*UWS;;T<G$4G3YP+QK43,/XWYQZM7XF1Q1DPA$X:<G?
M"9PGT!!GC?J\']1<8"(3N>3C[+D;^J&H_6RH_TY[0*36HT/N3VJ?[O@0)*W-
M'D@G'-+@TXD$6PJ66_!>\J+D_V$ULP((JLN'!.DRP$'#DA%A6HCVUW;K[O*"
M=.\:=Y?=>9RG!+T>3L8"3O92G @A3S#9-[YU+YM?.ZV[UF67--H7Y/+WYC\;
M[<^7I'ES?=WJ=ELW[1V2L,CFY23\1N4 0ILH#$[(A=[4(2@IVM4]D8&__VR6
MC-.]%X.KF\XUV=S/9"%CXG43-P/&IJ+]^M3'O.TTE YC%JR-9@%4L7/9OB.=
MR]N;SMT'Z[9@W6TL9$PAB8E"TF4N1N,)YF:!A(*8Q2/O.+D1]O:>&,R]@(A8
M\(@#U,NQ.X!8C)&&&Y&P1\QJP?XP;]N@B8$7<J[#1J&(R%%VS2B$7DQ&A-UC
M BS48^8=UUY@"V]5/'>91'DYDB2%$*6-HYH'=[0A@!C@9YI')]H$AM98,(W1
M<_5K.B&6=:)2Z@\K^A=\V;8Y68?UN<1$/FK#DVQ&"F".&QT()EN--KG[YV6G
M<7OY]:[5[)XD;&BUF_JST[1O>G!T.:9@0Y #*/YB2CFADL@1<S$K\@@/"(\D
M :L#VB".#T+ZAE3T(;.)PE$-4YIE'(^HX[/L?2<4D%-I@+Q/1Y+5LC].L[0_
M*5]HZJ/3%+H31E$X5 /<,Q%QE_KI(&J\Y'&:3E6K>J580'F,('6+O&S@--G2
M@:;\T_M652]7"TL?&;JY]/Y*4'JQM/S)UI#V%BE[+:B\XGS"?9A?E)SS7"&7
MO3RB'M9$:]9H3,QE,O-DDL/1]\]QC)?8M%;@A@*<F2I+=B/P/\TP#B(Q:8;>
MO'/"4BF6,2(V$N$]PGGT2C9X3N;3!RJ6U(Y2/8R\%[#79[TG&I0HSZOS]SG;
M8BRQ+2^BZ=!%YHK[#%YVP%2FTU_$XIFI%<KE:N5C_M_[_-_1<2LMC+K*;,P+
M0RE7MTJ:6;(LTS362L-K6]TW$HQG(R;%Q2-E/#&%#"$K$^0/2,JDQU6"252!
M%.(H/FMMCS]4XQ#FM1D.AUSB$JF:1;1^))'XCPD\B EL=;KD<CCRPPD3:@KG
MK1=IA_KQ4[N45_'\GN<R;YXN+F*Y/)'>[?K%9L7_;;U<P_,$DS+]WQ> 9V8>
MKIRKEPV;_%\,YIR1&X'IKP<X4N]DT=]M41Z:&[8)?]Z(N_!A&F)7<O7/E*-K
MD4XL^J\VDG);-^(68GJN5M23X:JY^O7%:XUQ&T+>X/^+CY*D(ET&,"!0,"KE
M)Q'C%K*4F!X>H$+7S*):I-Q5Q22E%<LE(P&LY"/J$S9F;ASQ>ZRB@,%A\O@(
MV$"0#V]>+3G4RNQR_3W:7/90>1J"T3EI,W/UDOEDQ\3Q%B+])02/=CL(@X7L
MQ[1R]:I5T$S@[VO)LJ5;NQ/EQSKGWW^N6&;Y5)*(^6R$I)- T7Z"H:P?8QA
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MT?6[WT=_N)"'YT=+:PV'-\%Z\@M02P,$%     @ %SFV6(HO>/"!"@  !%D
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MH3B!6MOBU8I\9*P:K> _:[7_VN/4]K\?(V]7;OA8&W+"IC-Y+US:D4;#I-/
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M,/YY^FK]3+;\I[FGK_X'4$L#!!0    ( !<YME@B; (X^ 8  #,S   5
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M A*WPGM%\VFLAG<R8"&_CA'21$0/X"%F@\))'XAJ4]4YVV$DOH<0M*BD8F(
M]XQ48L4DL+)5E;&(Y@VJ0L8QY=30#"UM<;Y.ET13*JP!H5S8"=2,9R0P>$F*
M4#!9$&VII!U%;7]=@7".K(OH=S.J^LJ #5#1&,AX"L74=BE.:PJ!D\13MMZ
M6T);1,943Z OLN5&(.E,H!PB4(:5.EFS:+)FD\<U,BM$8$]C=Q^(PJ10R  #
MY^0;B#4K$LB#N6B_!.YXDNM,#?V,B]>2$3E0 /[:E"&6!AP!E86PR/02&VN8
MAU!S"A'XJL:W"29Q*ZJ0$CD(L,Y"$@F@YZN A[2(5TN(69>%\F%C> '&DCK6
MB:N36:]0HUB>D- ;BC-9ADT+5YG2\2!*?UJ%]2=09*;AN>RC4+VD9,;A0/N<
M0!G74(FII[-6]N[D,"2H1 &6A$QF%B0 20I'SPF<*,"#QC*K?JLI<,D\F)]&
MN_7(;W],3:@&U VR(39(IB#]=>)_]/_/A9\K8O^:[:R!YP+>")>>4R0 <QMV
M^H.M9J! 3&R[1>QDV=KL#JHR^KJ4];H4_Y%E3=%.5=1@E>:^>3C>WSZZSQGW
M]I\DXT\KT!%K(U5@%6R00X9<^@I*D0((EGWW8.9]Y0ZWMA:+Q<BI9#0U\ZT3
MF\RHB;&ETJFT6Y3>MJ"N\>[>D_V#I_R?X]WM)_OC'2R+E?:VRN4.O3\XV+W9
M^47=/'LVW!G-?/'@,^^R+<:.M^3S_SL4!*-7QFG.0'ZA\KD:%A@W0T 0#@[K
MJD,>"%\C:9"1-/3T.M9)1,AP.81**9Y0%@<.P<,'8B-\92P\E<4 3:4'.(N/
M<R++>891FAJ/&82GI%8\FZ.2,98S(#"@S2E,T&:J,"W5)!A/4=I0BDY5E:N8
M7K@VH%)G@C2K N%ODB+0I$-(=8%\,5<%;Q-"@BDY2LG:+T7DR%B 5B9,0:T^
M),K4T6E%V3H%>4/N-I/ \D:;RFA>45*=4"F2YT.4<409%'$_4G!I1(KL-*0\
MSGKPY@9$ OI",DN6GM@B<<2<LZU;EBE,&:A#J6IKXN?+KPSJKE85\F:O[3Z&
MW''RB4 "24U!SCN EFMXS)"*0_RJ<IFHB1G"S[R%7<E(=W7_-FCUHS>G5]N[
MX]W][;WQ8^X/QL;?W]8(_3WHDPD%:7^'[.^ZTX_I @::?ZNE]P%-/$*?7D;2
MT]<;B:N[FD$HN)4?W"K/6:0/J<_AEFT<M+5!MW0E">\&^XTFW4B<Q#H>\\29
M.0TPU@(($5)E&5#?+9$!"IV(O*Y0U"B[Q%2%],;5L3+FGA;!*0:\?G,VH*8!
MX2/].9'N6OD0CXS/<K5P1X.QO"$"WZ_$6X:K=*48+#"KP>@DKU%"=-0[WJ.:
ML"1'; H[+K16K3?*+D/JGG44_97%_,O8'VGZ%&\]DA5GRK_K/OLC_@0A[-J]
MA4Z)YO+#N3;=2@9 +DAK3X4ZE8*)#T['2:1TL1 WCMZT!6STQ4'TLR[IX4P?
M?:LC@57@PFE#.F[[,G6+?JO)3RV+9Y(X0]_'!8J$#+5MX#")K.1$YTPI6-CP
M:TEIU-45Y]$2=;MS5%A@$3@Y?VLRSJ8;39( ;BVFQ#AE-;2X!)0LE$TTH<D]
MDG9$H1SOJ1$64[( 0[-K D T_C@JG)ZU$Z]67C= NU+G&(9:>R731R*:VA%]
M;!:EN4WE8:+?F[8%/IYJ@GI %8%\V#X<F7HXMV$_)QXIIZ$!G7L->DIM'YE'
M1K<AZQK9X/.;#A[Q@[[=,!ONLTS3;-K$[\&]J,R$DM):F#EFIR O.42B*[Y+
M$4X+0C>7.D]3VD.#_+=<8G-T,R2D1@0#W(3[DDU/DTU[UVQ-LKD349H+%3M
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M0H5,5G>=X-621&ZZ(^37G_Q>W)?>3-X*?P]QB__^X_\ 4$L! A0#%     @
M%SFV6$>^ZQ"X$   )WP  !$              ( !     ')N86,M,C R-# U
M,C(N:'1M4$L! A0#%     @ %SFV6%-M@>6! @  O0<  !$
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?:6=N870N:'1M4$L%!@     %  4 4 $   HU      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>rnac-20240522_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rnac-20240522.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001453687</identifier>
        </entity>
        <period>
            <startDate>2024-05-22</startDate>
            <endDate>2024-05-22</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0001453687</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2024-05-22</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">CARTESIAN THERAPEUTICS,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-37798</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">26-1622110</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">704 Quince Orchard Road,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Gaithersburg,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">20878</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">923-1400</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock (Par Value $0.0001)</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">RNAC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
